Document:

EX-4.9

 Exhibit 4.9 

EYEPOINT PHARMACEUTICALS, INC. 

and 
  

 
 as Trustee 

INDENTURE 
 Dated as of
                , 
  

							
	ARTICLE 1 DEFINITIONS AND INCORPORATION BY REFERENCE	  	 	1	 
	 1.1
	  	Definitions	  	 	1	 
	 1.2
	  	Other Definitions	  	 	5	 
	 1.3
	  	Incorporation by Reference of Trust Indenture Act	  	 	5	 
	 1.4
	  	Rules of Construction	  	 	6	 
	ARTICLE 2 THE SECURITIES	  	 	6	 
	 2.1
	  	Issuable in Series	  	 	6	 
	 2.2
	  	Establishment of Terms of Series of Securities	  	 	7	 
	 2.3
	  	Execution and Authentication	  	 	9	 
	 2.4
	  	Registrar and Paying Agent	  	 	10	 
	 2.5
	  	Paying Agent to Hold Assets in Trust	  	 	11	 
	 2.6
	  	Securityholder Lists	  	 	11	 
	 2.7
	  	Transfer and Exchange	  	 	11	 
	 2.8
	  	Replacement Securities	  	 	12	 
	 2.9
	  	Outstanding Securities	  	 	13	 
	 2.10
	  	When Treasury Securities Disregarded; Determination Of Holders Action	  	 	13	 
	 2.11
	  	Temporary Securities	  	 	13	 
	 2.12
	  	Cancellation	  	 	14	 
	 2.13
	  	Payment of Interest; Defaulted Interest; Computation of Interest	  	 	14	 
	 2.14
	  	Cusip Number	  	 	14	 
	 2.15
	  	Provisions for Global Securities	  	 	15	 
	 2.16
	  	Persons Deemed Owners	  	 	16	 
	ARTICLE 3 REDEMPTION	  	 	16	 
	 3.1
	  	Notices to Trustee	  	 	16	 
	 3.2
	  	Selection by Trustee of Securities to be Redeemed	  	 	17	 
	 3.3
	  	Notice of Redemption	  	 	17	 
	 3.4
	  	Effect of Notice of Redemption	  	 	18	 
	 3.5
	  	Deposit of Redemption Price	  	 	18	 
	 3.6
	  	Securities Redeemed in Part	  	 	19	 
	 ARTICLE 4 COVENANTS
	  	 	19	 
	 4.1
	  	Payment of Securities	  	 	19	 
	 4.2
	  	SEC REPORTS	  	 	19	 
	 4.3
	  	Waiver of Stay, Extension or Usury Laws	  	 	19	 
	 4.4
	  	Compliance Certificate	  	 	20	 
	 4.5
	  	Corporate Existence	  	 	20	 
	ARTICLE 5 SUCCESSOR CORPORATION	  	 	20	 
	 5.1
	  	Limitation on Consolidation, Merger and Sale of Assets	  	 	20	 
	 5.2
	  	Successor Person Substituted	  	 	21	 
	ARTICLE 6 DEFAULTS AND REMEDIES	  	 	21	 
	 6.1
	  	Events of Default	  	 	21	 
	 6.2
	  	Acceleration	  	 	23	 
	 6.3
	  	Remedies	  	 	23	 
	 6.4
	  	Waiver of Past Defaults and Events of Default	  	 	24	 
	 6.5
	  	Control by Majority	  	 	24	 
	 6.6
	  	Limitation on Suits	  	 	24	 
	 6.7
	  	Rights of Holders to Receive Payment	  	 	25	 

  
 i 

							
	 6.8
	  	Collection Suit by Trustee	  	 	25	 
	 6.9
	  	Trustee May File Proofs of Claim	  	 	25	 
	 6.10
	  	Priorities	  	 	26	 
	 6.11
	  	Undertaking for Costs	  	 	26	 
	ARTICLE 7 TRUSTEE	  	 	26	 
	 7.1
	  	Duties of Trustee	  	 	26	 
	 7.2
	  	Rights of Trustee	  	 	27	 
	 7.3
	  	Individual Rights Of Trustee	  	 	28	 
	 7.4
	  	Trustee’s Disclaimer	  	 	29	 
	 7.5
	  	Notice of Default	  	 	29	 
	 7.6
	  	Reports by Trustee to Holders	  	 	29	 
	 7.7
	  	Compensation and Indemnity	  	 	29	 
	 7.8
	  	Replacement of Trustee	  	 	30	 
	 7.9
	  	Successor Trustee by Consolidation, Merger or Conversion	  	 	31	 
	 7.10
	  	Eligibility; Disqualification	  	 	31	 
	 7.11
	  	Preferential Collection of Claims Against Company	  	 	31	 
	 7.12
	  	Paying Agents	  	 	31	 
	ARTICLE 8 AMENDMENTS, SUPPLEMENTS AND WAIVERS	  	 	32	 
	 8.1
	  	Without Consent of Holders	  	 	32	 
	 8.2
	  	With Consent of Holders	  	 	33	 
	 8.3
	  	Compliance With Trust Indenture Act	  	 	34	 
	 8.4
	  	Revocation and Effect of Consents	  	 	34	 
	 8.5
	  	Notation On or Exchange of Securities	  	 	35	 
	 8.6
	  	Trustee To Sign Amendments, Etc	  	 	35	 
	ARTICLE 9 DISCHARGE OF INDENTURE; DEFEASANCE	  	 	35	 
	 9.1
	  	Discharge of Indenture	  	 	35	 
	 9.2
	  	Legal Defeasance	  	 	35	 
	 9.3
	  	Covenant Defeasance	  	 	36	 
	 9.4
	  	Conditions to Legal Defeasance or Covenant Defeasance	  	 	36	 
	 9.5
	  	Deposited Money And U.S. And Foreign Government Obligations To Be Held In Trust; Other Miscellaneous Provisions	  	 	38	 
	 9.6
	  	Reinstatement	  	 	38	 
	 9.7
	  	Moneys Held by Paying Agent	  	 	39	 
	 9.8
	  	Moneys Held by Trustee	  	 	39	 
	ARTICLE 10 MISCELLANEOUS	  	 	39	 
	 10.1
	  	Trust Indenture Act Controls	  	 	39	 
	 10.2
	  	Notices	  	 	40	 
	 10.3
	  	Communications by Holders With Other Holders	  	 	41	 
	 10.4
	  	Certificate and Opinion as to Conditions Precedent	  	 	41	 
	 10.5
	  	Statement Required in Certificate and Opinion	  	 	41	 
	 10.6
	  	Rules by Trustee and Agents	  	 	41	 
	 10.7
	  	Business Days; Legal Holidays; Place of Payment	  	 	42	 
	 10.8
	  	Governing Law	  	 	42	 
	 10.9
	  	No Adverse Interpretation of Other Agreements	  	 	42	 
	 10.10
	  	Successors	  	 	42	 
	 10.11
	  	Multiple Counterparts	  	 	42	 

  
 ii 

							
	 10.12
	  	Table of Contents, Headings, Etc	  	 	42	 
	 10.13
	  	Severability	  	 	43	 
	 10.14
	  	Securities in a Foreign Currency or in Euros	  	 	43	 
	 10.15
	  	Judgment Currency	  	 	44	 
	 10.16
	  	Force Majeure	  	 	44	 
	 10.17
	  	U.S.A. Patriot Act	  	 	44	 
	ARTICLE 11 SINKING FUNDS	  	 	45	 
	 11.1
	  	Applicability of Article	  	 	45	 
	 11.2
	  	Satisfaction of Sinking Fund Payments with Securities	  	 	45	 
	 11.3
	  	Redemption of Securities for Sinking Fund	  	 	45	 

  

  
 iii 

 INDENTURE, dated as of
                , by and between EyePoint Pharmaceuticals, Inc., a Delaware corporation, as Issuer (the “Company”), and
                , a                 , organized under the laws of
                , as Trustee (the “Trustee”). 

RECITALS OF THE COMPANY 

The Company has duly authorized the execution and delivery of this Indenture to provide for the issuance from time to time of its debentures,
notes or other evidences of indebtedness to be issued in one or more series (the “Securities”), as herein provided, up to such principal amount as may from time to time be authorized in or pursuant to one or more resolutions of the
Board of Directors or by supplemental indenture. 
 All things necessary to make this Indenture a valid agreement of the Company in
accordance with its terms have been done, and the execution and delivery thereof have been in all respects duly authorized by the parties hereto. 

NOW, THEREFORE, THIS INDENTURE WITNESSETH: For and in consideration of the premises and the purchase of the Securities by the Holders
thereof, it is mutually agreed, for the equal and proportionate benefit of all Holders of the Securities of a Series thereof, as follows: 

ARTICLE 1 
 DEFINITIONS
AND INCORPORATION BY REFERENCE 
 1.1    Definitions. 

“Affiliate” of any specified Person means any other Person which, directly or indirectly through one or more intermediaries,
controls, or is controlled by or is under common control with, such specified Person. For the purposes of this definition, “control” (including, with correlative meanings, the terms “controlling,” “controlled by” and
“under common control with”), as used with respect to any Person, means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of such Person, whether through the ownership of
voting securities, by agreement or otherwise. 
 “Agent” means any Registrar, Paying Agent,
co-registrar or agent for service of notices and demands. 
 “Board of Directors”
means the Board of Directors of the Company or any committee duly authorized to act therefor. 
 “Board Resolution” means a
copy of a resolution certified pursuant to an Officers’ Certificate to have been duly adopted by the Board of Directors of the Company and to be in full force and effect on the date of such certification which has been delivered to the Trustee.

 “Capital Stock” means, with respect to any Person, any and all shares or other equivalents (however designated) of
capital stock, partnership interests or any other participation, right or other interest in the nature of an equity interest in such Person or any option, warrant or other security convertible into any of the foregoing. 

  
 1 

 “Company” means the party named as such in the first paragraph of this
Indenture until a successor replaces such party pursuant to ARTICLE 5 of this Indenture, and thereafter means the successor and any other primary obligor on the Securities. 

“Company Order” means a written order signed in the name of the Company by two of the Company’s executive Officers, one
of whom must be its Chief Executive Officer or its Chief Financial Officer. 
 “Company Request” means any written request
signed in the name of the Company by its Chief Executive Officer, its President, any Vice President, its Chief Financial Officer or its Treasurer and attested to by its Secretary or any Assistant Secretary. 

“Corporate Trust Office” means the office of the Trustee at which at any particular time its corporate trust business shall
be principally administered. 
 “Default” means any event that is, or that with the passing of time or giving of notice or
both would be, an Event of Default. 
 “Depository” means, with respect to the Securities of any Series issuable or
issued in whole or in part in the form of one or more Global Securities, the Person designated as Depository for such Series by the Company, which Depository shall be a clearing agency registered under the Exchange Act, until a successor
Depository shall have become such pursuant to the applicable provisions of this Indenture, and thereafter “Depository” shall mean each Person who is then a Depository hereunder, and if at any time there is more than one such Person, such
Persons. 
 “Dollars” means the currency of the United States of America. 

“Euro” means the single currency of participating member states of the economic and monetary union as contemplated in the
Treaty on European Union. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended. 

“Foreign Currency” means any currency or currency unit issued by a government other than the government of the United States
of America. 
 “Foreign Government Obligations” means, with respect to Securities that are denominated in a Foreign
Currency, (i) direct obligations of the government that issued or caused to be issued such currency for the payment of which obligations its full faith and credit is pledged or (ii) obligations of a Person controlled or supervised by, or
acting as an agency or instrumentality of, such government, the timely payment of which is unconditionally guaranteed as a full faith and credit obligation by such government, which, in either case under clauses (i) and (ii), are not callable
or redeemable at the option of the issuer thereof. 

  
 2 

 “GAAP” means generally accepted accounting principles consistently applied
as in effect in the United States of America from time to time. 
 “Global Security” or “Global Securities” means
a Security or Securities, as the case may be, in the form established pursuant to Section 2.2, evidencing all or part of a Series of Securities issued to the Depository for such Series or its nominee, and
registered in the name of such Depository or nominee, and bearing the legend set forth in Section 2.15(c) (or such other legend(s) as may be applied to such Securities in accordance with
Section 2.2(24)). 
 “Holder” or “Securityholder” means the Person in whose name
a Security is registered on the Registrar’s books. 
 “Indebtedness” means (without duplication), with respect to any
Person, any indebtedness at any time outstanding, secured or unsecured, contingent or otherwise, which is for borrowed money (whether or not the recourse of the lender is to the whole of the assets of such Person or only to a portion thereof), or
evidenced by bonds, notes, debentures or similar instruments, or representing the balance deferred and unpaid of the purchase price of any property (excluding any balances that constitute accounts payable or trade payables, and other accrued
liabilities arising in the ordinary course of business), if and to the extent any of the foregoing indebtedness would appear as a liability upon a balance sheet of such Person prepared in accordance with GAAP. 

“Indenture” means this Indenture as amended, restated or supplemented from time to time. 

“Interest Payment Date” when used with respect to any Security, means the Stated Maturity of an installment of interest on
such Security. 
 “Lien” means, with respect to any property or assets of any Person, any mortgage or deed of trust,
pledge, hypothecation, assignment, deposit arrangement, security interest, lien, charge, easement, encumbrance, preference, priority or other security agreement or preferential arrangement of any kind or nature whatsoever on or with respect to such
property or assets (including, without limitation, any capitalized lease obligation, conditional sales or other title retention agreement having substantially the same economic effect as any of the foregoing). 

“Maturity” when used with respect to any Security, means the date on which the principal of such Security, or an installment
of principal, becomes due and payable as therein or herein provided, whether at the Stated Maturity or by declaration of acceleration, call for redemption, notice of option to elect payment or otherwise. 

“Officer” means the Chief Executive Officer, the President, any Vice President, the Chief Financial Officer, the Treasurer or
the Secretary of the Company, or any other officer designated by the Board of Directors, as the case may be. 
 “Officers’
Certificate” means, with respect to any Person, a certificate signed by the Chairman, Chief Executive Officer, President or any Senior or Executive Vice President and the Chief Financial Officer or any Treasurer of such Person, that shall
comply with applicable provisions of this Indenture. 

  
 3 

 “Opinion of Counsel” means a written opinion from legal counsel, which
counsel is reasonably acceptable to the Trustee. The counsel may be an employee of or counsel to the Company. 
 “Person”
means any individual, corporation, limited liability company, partnership, joint venture, association, joint-stock company, trust, unincorporated organization or government (including any agency or political subdivision thereof). 

“Redemption Date,” when used with respect to any Security to be redeemed, means the date fixed for such redemption pursuant
to this Indenture. 
 “Responsible Officer,” when used with respect to the Trustee, means any officer within the corporate
trust department or division of the Trustee (or any successor group of the Trustee) or any other officer of the Trustee customarily performing functions similar to those performed by any of the above designated officers, and also means, with respect
to a particular corporate trust matter, any other officer to whom such matter is referred because of his knowledge of and familiarity with the particular subject. 

“SEC” means the United States Securities and Exchange Commission as constituted from time to time, or any successor
performing substantially the same functions. 
 “Securities” means the securities that are issued under this Indenture, as
amended or supplemented from time to time pursuant to this Indenture. 
 “Securities Act” means the Securities Act of 1933,
as amended. 
 “Series” or “Series of Securities” means each series of debentures,
notes or other debt instruments of the Company created pursuant to Sections 2.1 and 2.2. 

“Significant Subsidiary” means (i) any direct or indirect Subsidiary of the Company that would be a “significant
subsidiary” as defined in Article 1, Rule 1-02 of Regulation S-X, promulgated pursuant to the Securities Act, as such regulation is in effect on the date
hereof, or (ii) any group of direct or indirect Subsidiaries of the Company that, taken together as a group, would be a “significant subsidiary” as defined in Article 1, Rule 1-02 of
Regulation S-X, promulgated pursuant to the Securities Act, as such regulation is in effect on the date hereof. 

“Stated Maturity” when used with respect to any Security or any installment of principal thereof or interest thereon, means
the date specified in such Security as the fixed date on which the principal of such Security, or such installment of principal or interest, is due and payable, and when used with respect to any other Indebtedness, means the date specified in the
instrument governing such Indebtedness as the fixed date on which the principal of such Indebtedness, or any installment of interest thereon, is due and payable. 

“Subsidiary” of any specified Person means any corporation, limited liability company, partnership, joint venture,
association or other business entity, whether now existing or hereafter organized or acquired, (i) in the case of a corporation, of which more than 50% of the total voting power of the Capital Stock entitled (without regard to the occurrence of
any contingency) to vote in the election of directors thereof is held, directly or indirectly, by such Person or any of its Subsidiaries; or (ii) in the case of a partnership, joint venture, association or other business entity, with respect to
which such Person or any of its Subsidiaries has the power to direct or cause the direction of the management and policies of such entity by contract or otherwise, or if in accordance with GAAP such entity is consolidated with such Person for
financial statement purposes. 

  
 4 

 “TIA” means the Trust Indenture Act of 1939 (15 U.S. Code
Section 77aaa-77bbbb) as in effect on the date of this Indenture (except as provided in Section 8.3). 

“Trustee” means the party named as such in this Indenture until a successor replaces it pursuant to this Indenture, and
thereafter means the successor, and if at any time there is more than one such Person, “Trustee” as used with respect to the Securities of any Series shall mean the Trustee with respect to Securities of that Series. 

“U.S. Government Obligations” means direct non-callable obligations of, or non-callable obligations guaranteed by, the United States of America for the payment of which obligation or guarantee the full faith and credit of the United States of America is pledged. 

1.2    Other Definitions. 

The definitions of the following terms may be found in the sections indicated as follows: 

 

					
	 TERM
	  	DEFINED IN SECTION	 
	 “Bankruptcy Law”
	  	 	6.1	 
	 “Business Day”
	  	 	10.7	 
	 “Covenant Defeasance”
	  	 	9.3	 
	 “Custodian”
	  	 	6.1	 
	 “Event of Default”
	  	 	6.1	 
	 “Journal”
	  	 	10.14	 
	 “Judgment Currency”
	  	 	10.15	 
	 “Legal Defeasance”
	  	 	9.2	 
	 “Legal Holiday”
	  	 	10.7	 
	 “Market Exchange Rate”
	  	 	10.14	 
	 “New York Paying Agent”
	  	 	2.4	 
	 “Paying Agent”
	  	 	2.4	 
	 “Place of Payment”
	  	 	10.7	 
	 “Registrar”
	  	 	2.4	 
	 “Required Currency”
	  	 	10.15	 
	 “Service Agent”
	  	 	2.4	 

 1.3    Incorporation by Reference of Trust Indenture Act. 

Whenever this Indenture refers to a provision of the TIA, the portion of such provision required to be incorporated herein in order for this
Indenture to be qualified under the TIA is incorporated by reference in and made a part of this Indenture. The following TIA terms used in this Indenture have the following meanings: 

  
 5 

 “Commission” means the SEC. 

“indenture securities” means the Securities. 

“indenture securityholder” means a Holder or Securityholder. 

“indenture to be qualified” means this Indenture. 

“indenture trustee” or “institutional trustee” means the Trustee. 

“obligor on the indenture securities” means the Company. 

All other terms used in this Indenture that are defined by the TIA, defined in the TIA by reference to another statute or defined by SEC
rule have the meanings therein assigned to them. 
 1.4    Rules of Construction. 

Unless the context otherwise requires: 

(1)    a term has the meaning assigned to it herein, whether defined expressly or by reference; 

(2)    an accounting term not otherwise defined has the meaning assigned to it in accordance with GAAP; 

(3)    “or” is not exclusive; 

(4)    words in the singular include the plural, and in the plural include the singular; 

(5)    words used herein implying any gender shall apply to each gender; and 

(6)    the words “herein”, “hereof” and “hereunder” and other words of similar import refer
to this Indenture as a whole and not to any particular Article, Section or other subdivision. 
 ARTICLE 2 

THE SECURITIES 

2.1    Issuable in Series. 

The aggregate principal amount of Securities that may be authenticated and delivered under this Indenture is
$                . The Securities may be issued in one or more Series. All Securities of a Series shall be identical except as may be set forth in a Board
Resolution, a supplemental indenture or an Officers’ Certificate detailing the adoption of the terms thereof pursuant to the authority granted under a Board Resolution. In the case of Securities of a Series to be issued from time to time,
the Board Resolution, Officers’ Certificate or supplemental indenture may provide for the method by which specified terms (such as interest rate, Stated Maturity, record date or date from which interest shall accrue) are to be determined.
Securities may differ between Series in respect of any matters, PROVIDED, that all Series of Securities shall be equally and ratably entitled to the benefits of the Indenture. 

  
 6 

 2.2    Establishment of Terms of Series of Securities. 

At or prior to the issuance of any Securities within a Series, the following shall be established (as to the Series generally, in the
case of Subsection 2.2(1) and either as to such Securities within the Series or as to the Series generally in the case of Subsections 2.2(2) through 2.2(24)) by a Board Resolution,
a supplemental indenture or an Officers’ Certificate, in each case, pursuant to authority granted under a Board Resolution: 

(1)    the title of the Series (which shall distinguish the Securities of that particular Series from the
Securities of any other Series); 
 (2)    any limit upon the aggregate principal amount of the Securities of the
Series which may be authenticated and delivered under this Indenture (except for Securities authenticated and delivered upon registration of transfer of, or in exchange for, or in lieu of, other Securities of the Series pursuant to
Sections 2.7, 2.8, 2.11, 3.6 or 8.5); 
 (3)    the price or prices (expressed
as a percentage of the principal amount thereof) at which the Securities of the Series will be issued; 

(4)    the date or dates on which the principal of the Securities of the Series is payable; 

(5)    the rate or rates (which may be fixed or variable) per annum or, if applicable, the method used to determine such
rate or rates (including, but not limited to, any commodity, commodity index, stock exchange index or financial index) at which the Securities of the Series shall bear interest, if any, the date or dates from which such interest, if any, shall
accrue, the date or dates on which such interest, if any, shall commence and be payable and any regular record date for the interest payable on any Interest Payment Date; 

(6)    the place or places where the principal of, and interest and premium, if any, on, the Securities of the
Series shall be payable, or the method of such payment, if by wire transfer, mail or other means; 
 (7)    if
applicable, the period or periods within which, the price or prices at which and the terms and conditions upon which the Securities of the Series may be redeemed, in whole or in part, at the option of the Company; 

(8)    the obligation, if any, of the Company to redeem or purchase the Securities of the Series pursuant to any
sinking fund or analogous provisions or at the option of a Holder thereof, and the period or periods within which, the price or prices at which and the terms and conditions upon which Securities of the Series shall be redeemed or
purchased, in whole or in part, pursuant to such obligation; 

  
 7 

 (9)    the dates, if any, on which and the price or prices at which the
Securities of the Series will be repurchased by the Company at the option of the Holders thereof, and other detailed terms and provisions of such repurchase obligations; 

(10)    if other than denominations of $1,000 and any integral multiple thereof, the denominations in which the Securities
of the Series shall be issuable; 
 (11)    the forms of the Securities of the Series in bearer (if to be
issued outside of the United States of America) or fully registered form (and, if in fully registered form, whether the Securities will be issuable as Global Securities); 

(12)    if other than the principal amount thereof, the portion of the principal amount of the Securities of the
Series that shall be payable upon declaration of acceleration of the Maturity thereof pursuant to Section 6.2; 

(13)    the currency of denomination of the Securities of the Series, which may be Dollars or any Foreign Currency,
including, but not limited to, the Euro, and, if such currency of denomination is a composite currency other than the Euro, the agency or organization, if any, responsible for overseeing such composite currency; 

(14)    the designation of the currency, currencies or currency units in which payment of the principal of, and interest
and premium, if any, on, the Securities of the Series will be made; 
 (15)    if payments of principal of, or
interest or premium, if any, on, the Securities of the Series are to be made in one or more currencies or currency units other than that or those in which such Securities are denominated, the manner in which the exchange rate with respect to
such payments will be determined; 
 (16)    the manner in which the amounts of payment of principal of, or interest and
premium, if any, on, the Securities of the Series will be determined, if such amounts may be determined by reference to an index based on a currency or currencies or by reference to a commodity, commodity index, stock exchange index or
financial index; 
 (17)    the provisions, if any, relating to any collateral provided for the Securities of the
Series; 
 (18)    any addition to or change in the covenants set forth in Articles 4 or 5 that applies to Securities of
the Series; 
 (19)    any addition to or change in the Events of Default which applies to any Securities of the Series,
and any change in the right of the Trustee or the requisite Holders of such Securities to declare the principal amount thereof due and payable pursuant to Section 6.2; 

(20)    the terms and conditions, if any, for conversion of the Securities into or exchange of the Securities for shares
of common stock or preferred stock of the Company that apply to Securities of the Series; 

  
 8 

 (21)    any depositories, interest rate calculation agents, exchange
rate calculation agents or other agents with respect to Securities of such Series if other than those appointed herein; 

(22)    the terms and conditions, if any, upon which the Securities shall be subordinated in right of payment to other
Indebtedness of the Company; 
 (23)    if applicable, that the Securities of the Series, in whole or any specified
part, shall be defeasible pursuant to ARTICLE 9; and 
 (24)    (24) any other terms of the Securities of
the Series (which terms shall not be inconsistent with the provisions of this Indenture, except as permitted by Section 8.1, but which may modify or delete any provision of this Indenture insofar as it applies to such Series). 

All Securities of any one Series need not be issued at the same time, and may be issued from time to time, consistent with the terms of
this Indenture, if so provided by or pursuant to the Board Resolution, supplemental indenture or Officers’ Certificate referred to above, however, the authorized principal amount of any Series may not be increased to provide for issuances
of additional Securities of such Series, unless otherwise provided in such Board Resolution, supplemental indenture or Officers’ Certificate. 

2.3    Execution and Authentication. 

The Securities shall be executed on behalf of the Company by two Officers of the Company or an Officer and an Assistant Secretary of the
Company. Each such signature may be either manual or facsimile. The Company’s seal may be impressed, affixed, imprinted or reproduced on the Securities and may be in facsimile form. 

If an Officer whose signature is on a Security no longer holds that office at the time the Security is authenticated, the Security shall
nevertheless be valid. 
 A Security shall not be valid until authenticated by the manual signature of the Trustee or an authenticating
agent. The signature shall be conclusive evidence that the Security has been authenticated under this Indenture. The Trustee shall at any time, and from time to time, authenticate Securities for original issue in the principal amount provided in the
Board Resolution, supplemental indenture hereto or Officers’ Certificate, upon receipt by the Trustee of a Company Order. Such Company Order may authorize authentication and delivery pursuant to oral or electronic instructions from the Company
or its duly authorized agent or agents, which oral instructions shall be promptly confirmed in writing. Each Security shall be dated the date of its authentication. 

The aggregate principal amount of Securities of any Series outstanding at any time may not exceed any limit upon the maximum principal
amount for such Series set forth in the Board Resolution, supplemental indenture hereto or Officers’ Certificate delivered pursuant to Section 2.2, except as provided in Section 2.8. 

  
 9 

 Prior to the issuance of Securities of any Series, the Trustee shall have received and
(subject to Section 7.1) shall be fully protected in relying on: (a) the Board Resolution, supplemental indenture hereto or Officers’ Certificate establishing the form of the Securities of that Series or of
Securities within that Series and the terms of the Securities of that Series or of Securities within that Series, (b) an Officers’ Certificate complying with Section 10.4, and (c) an Opinion of
Counsel complying with Section 10.4. 
 The Trustee shall have the right to decline to authenticate and deliver
any Securities of any Series: (a) if the Trustee, being advised in writing by outside counsel, determines that such action may not lawfully be taken; or (b) if the Trustee in good faith by its board of directors or trustees, executive
committee or a trust committee of directors and/or vice-presidents shall reasonably determine that such action would expose the Trustee to personal liability, or cause it to have a conflict of interest with respect to Holders of any then outstanding
Series of Securities. 
 The Trustee may appoint an authenticating agent acceptable to the Company to authenticate Securities. An
authenticating agent may authenticate Securities whenever the Trustee may do so. Any appointment shall be evidenced by an instrument signed by an authorized officer of the Trustee, a copy of which shall be furnished to the Company. Each reference in
this Indenture to authentication by the Trustee includes authentication by such agent. An authenticating agent has the same rights as an Agent to deal with the Company or an Affiliate of the Company. 

2.4    Registrar and Paying Agent. 

The Company shall maintain in each Place of Payment for any Series of Securities (i) an office or agency where such Securities may
be presented for registration of transfer or for exchange (“Registrar”), (ii) an office or agency where such Securities may be presented for payment (“Paying Agent”) (PROVIDED that the Company shall at all
times maintain a Paying Agent in the Borough of Manhattan, City of New York, State of New York (the “New York Paying Agent”), and PROVIDED, FURTHER, that at the option of the Company payment of interest may be made by check mailed
to the address of the Person entitled thereto as such address shall appear in the register for the Securities maintained by the Registrar), and (iii) an office or agency where notices and demands to or upon the Company in respect of the
Securities and this Indenture may be served (“Service Agent”). The Registrar shall keep a register of the Securities and of their transfer and exchange. The Company may have one or more
co-registrars and one or more additional paying agents. The Company shall give prompt written notice to the Trustee of the location, and any change in the location, of such office or agency. If at any time the
Company shall fail to maintain any such required office, or to furnish the Trustee with the address thereof, such presentations, surrenders, notices and demands may be made or served at the address of the Trustee as set forth in
Section 10.2. If the Company acts as Paying Agent, it shall segregate the money held by it for the payment of principal of, and interest and premium, if any, on, the Securities and hold it as a separate trust fund. The
Company may change any Paying Agent, Registrar, co-registrar or any other Agent without notice to any Securityholder. 

The Company may also from time to time designate one or more other offices or agencies where the Securities may be presented or surrendered
for any or all such purposes, and may from time to time rescind such designations; PROVIDED, HOWEVER, that no such designation or rescission shall in any manner relieve the Company of its obligation to maintain an office or agency in each Place of
Payment for Securities of any Series for such purposes. The Company hereby initially designates the Corporate Trust Office of the Trustee as such office of the Company. The Company shall give prompt written notice to the Trustee of such
designation or rescission, and of any change in the location of any such other office or agency. 

  
 10 

 The Company shall enter into an appropriate agency agreement with any Registrar or Paying
Agent not a party to this Indenture. The agreement shall implement the provisions of this Indenture that relate to such Agent. The Company shall notify the Trustee of the name and address of any such Agent. If the Company fails to maintain a
Registrar or Paying Agent, or agent for service of notices and demands, or fails to give the foregoing notice, the Trustee shall act as such. The Company hereby appoints the Trustee as the initial Registrar, Paying Agent and Service Agent for each
Series unless another Registrar, Paying Agent or Service Agent, as the case may be, is appointed prior to the time Securities of that Series are first issued. The Company designates
                    , as the New York Paying Agent, with offices at
                    . 

2.5    Paying Agent to Hold Assets in Trust. 

The Trustee as Paying Agent shall, and the Company shall require each Paying Agent other than the Trustee to agree in writing that each Paying
Agent shall, hold in trust for the benefit of the Holders of any Series of Securities or the Trustee all assets held by the Paying Agent for the payment of principal of, or interest or premium, if any, on, such Series of Securities
(whether such assets have been distributed to it by the Company or any other obligor on such Series of Securities), and the Company and the Paying Agent shall notify the Trustee in writing of any Default by the Company (or any other obligor on
such Series of Securities) in making any such payment. The Company at any time may require a Paying Agent to distribute all assets held by it to the Trustee and account for any assets disbursed, and the Trustee may, at any time during the
continuance of any payment default with respect to any Series of Securities, upon written request to a Paying Agent, require such Paying Agent to distribute all assets held by it to the Trustee and to account for any assets distributed. Upon
distribution to the Trustee of all assets that shall have been delivered by the Company to the Paying Agent, the Paying Agent shall have no further liability for such assets. 

2.6    Securityholder Lists. 

The Trustee shall preserve in as current a form as is reasonably practicable the most recent list available to it of the names and addresses
of Securityholders of each Series of Securities. If the Trustee is not the Registrar, the Company shall furnish to the Trustee as of each regular record date for the payment of interest on the Securities of a Series and before each related
Interest Payment Date, and at such other times as the Trustee may request in writing, a list in such form and as of such date as the Trustee may reasonably require of the names and addresses of Securityholders of each Series of Securities. 

2.7    Transfer and Exchange. 

When Securities of a Series are presented to the Registrar with a request to register the transfer thereof, the Registrar shall register
the transfer as requested if the requirements of applicable law are met, and when such Securities of a Series are presented to the Registrar with a request to exchange them for an equal principal amount of other authorized denominations of
Securities of the same Series, the Registrar shall make the exchange as requested. To permit transfers and exchanges, upon surrender of any Security for registration of transfer at the office or agency maintained pursuant to Section 2.4,
the Company shall execute and the Trustee shall authenticate Securities at the Registrar’s request. 

  
 11 

 If Securities are issued as Global Securities, the provisions of
Section 2.15 shall apply. 
 All Securities issued upon any registration of transfer or exchange of Securities
shall be the valid obligations of the Company, evidencing the same debt, and entitled to the same benefits under this Indenture, as the Securities surrendered upon such registration of transfer or exchange. 

Every Security presented or surrendered for registration of transfer or for exchange shall (if so required by the Company or the Registrar or
a co-registrar) be duly endorsed, or be accompanied by a written instrument of transfer in form satisfactory to the Company and the Registrar or a co-registrar, duly
executed by the Holder thereof or his attorney duly authorized in writing. 
 Any exchange or transfer shall be without charge, except that
the Company may require payment by the Holder of a sum sufficient to cover any tax or other governmental charge that may be imposed in relation to a transfer or exchange, but this provision shall not apply to any exchange pursuant to
Section 2.11, 3.6 or 8.5. The Trustee shall not be required to register transfers of Securities of any Series, or to exchange Securities of any Series, for a period of 15 days before the record date for
selection for redemption of such Securities. The Trustee shall not be required to exchange or register transfers of Securities of any Series called or being called for redemption in whole or in part, except the unredeemed portion of such
Security being redeemed in part. 
 2.8    Replacement Securities. 

If a mutilated Security is surrendered to the Trustee, or if the Holder of a Security presents evidence to the satisfaction of the Company and
the Trustee that the Security has been lost, destroyed or wrongfully taken, the Company shall issue and the Trustee shall authenticate a replacement Security of the same Series and of like tenor and principal amount and bearing a number not
contemporaneously outstanding. An indemnity bond may be required by the Company or the Trustee that is sufficient in the reasonable judgment of the Company or the Trustee, as the case may be, to protect the Company, the Trustee or any Agent from any
loss which any of them may suffer if a Security is replaced. The Company may charge such Holder for the Company’s out-of-pocket expenses in replacing a Security,
including the fees and expenses of the Trustee. Every replacement Security shall constitute an original additional obligation of the Company, whether or not the destroyed, lost or stolen Security shall be at any time enforceable by anyone, and shall
be entitled to all the benefits of this Indenture equally and proportionately with any and all other Securities of that Series duly issued hereunder. 

  
 12 

 2.9    Outstanding Securities. 

Securities outstanding at any time are all Securities authenticated by the Trustee, except for those canceled by it, those delivered to it for
cancellation and those described in this Section 2.9 as not outstanding. 
 If a Security is replaced pursuant to
Section 2.8 (other than a mutilated Security surrendered for replacement), it ceases to be outstanding until the Company and the Trustee receive proof satisfactory to each of them that the replaced Security is held by a
bona fide purchaser. A mutilated Security ceases to be outstanding upon surrender of such Security and replacement thereof pursuant to Section 2.8. 

If a Paying Agent holds on a Redemption Date or the Stated Maturity money sufficient to pay the principal of, premium, if any, and accrued
interest on, Securities payable on that date, and is not prohibited from paying such money to the Holders thereof pursuant to the terms of this Indenture (PROVIDED, that if such Securities are to be redeemed, notice of such redemption has been duly
given pursuant to this Indenture or provision therefor satisfactory to the Trustee has been made), then on and after that date such Securities cease to be outstanding and interest on them ceases to accrue. 

A Security does not cease to be outstanding solely because the Company or an Affiliate holds the Security. 

2.10    When Treasury Securities Disregarded; Determination Of Holders Action. 

In determining whether the Holders of the required aggregate principal amount of the Securities of any Series have concurred in any
direction, waiver or consent, the Securities of any Series owned by the Company or any other obligor on such Securities, or by any Affiliate of any of them, shall be disregarded, except that for the purposes of determining whether the Trustee
shall be protected in relying on any such direction, waiver or consent, only Securities of such Series which the Trustee actually knows are so owned shall be so disregarded. Securities of such Series so owned which have been pledged in
good faith shall not be disregarded if the pledgee establishes to the satisfaction of the Trustee the pledgee’s right so to act with respect to the Securities of such Series and that the pledgee is not the Company or any other obligor on
the Securities of such Series, or an Affiliate of any of them. 
 2.11    Temporary Securities. 

Until definitive Securities are ready for delivery, the Company may prepare and execute, and the Trustee shall authenticate, temporary
Securities. Temporary Securities shall be substantially in the form, and shall carry all rights, of definitive Securities, but may have variations that the Company considers appropriate for temporary Securities. Without unreasonable delay, the
Company shall prepare and execute, and the Trustee shall authenticate, definitive Securities in exchange for temporary Securities without charge to the Holder. 

  
 13 

 2.12    Cancellation. 

All Securities surrendered for payment, redemption or registration of transfer or exchange, or for credit against any sinking fund payment,
shall, if surrendered to any Person other than the Trustee, be delivered to the Trustee for cancellation. The Company may at any time deliver to the Trustee for cancellation any Securities previously authenticated and delivered hereunder which the
Company may have acquired in any manner whatsoever, and may deliver to the Trustee (or to any other Person for delivery to the Trustee) for cancellation any Securities previously authenticated hereunder which the Company has not issued and sold. The
Registrar and the Paying Agent shall forward to the Trustee any Securities surrendered to them for transfer, exchange or payment. The Trustee or, at the direction of the Trustee, the Registrar or the Paying Agent, and no one else, shall cancel, and
at the written request of the Company shall dispose of, all Securities surrendered for transfer, exchange, payment or cancellation. If the Company shall acquire any of the Securities, such acquisition shall not operate as a redemption or
satisfaction of the Indebtedness represented by such Securities unless and until the same are surrendered to the Trustee for cancellation pursuant to this Section 2.12. No Securities shall be authenticated in lieu of or in
exchange for any Securities cancelled as provided in this Section 2.12, except as expressly permitted by this Indenture. 

2.13    Payment of Interest; Defaulted Interest; Computation of Interest. 

Except as otherwise provided as contemplated by Section 2.2 with respect to any Series of Securities, interest
on any Security which is payable, and is punctually paid or duly provided for, on any Interest Payment Date shall be paid to the Person in whose name that Security is registered at the close of business on the regular record date for such interest,
as provided in the Board Resolution, supplemental indenture hereto or Officers’ Certificate establishing the terms of such Series. 

If the Company defaults in a payment of interest on the Securities, it shall pay the defaulted amounts, plus any interest payable on defaulted
amounts pursuant to Section 4.1, to the Persons who are Securityholders on a subsequent special record date, which date shall be the 15th day next preceding the date fixed by the Company for the payment of defaulted
interest, or the next succeeding Business Day if such date is not a Business Day. At least 15 days before the special record date, the Company shall mail or cause to be mailed to each Securityholder, with a copy to the Trustee, a notice that states
the special record date, the payment date and the amount of defaulted interest, and interest payable on such defaulted interest, if any, to be paid. 

Except as otherwise specified as contemplated by Section 2.2 for Securities of any Series, interest on the
Securities of each Series shall be computed on the basis of a 360-day year of twelve 30-day months. 

2.14    Cusip Number. 

The Company in issuing the Securities may use one or more “CUSIP” numbers, and, if the Company does so, the Trustee shall use
the CUSIP number(s) in notices of redemption or exchange as a convenience to Holders, PROVIDED, that any such notice may state that no representation is made as to the correctness or accuracy of the CUSIP number(s) printed in the notice or
on the Securities, and that reliance may be placed only on the other identification numbers printed on the Securities, and that any such redemption or exchange shall not be affected by any defect in or omission of any such numbers. 

  
 14 

 2.15    Provisions for Global Securities. 

(a)    A Board Resolution, a supplemental indenture hereto or an Officers’ Certificate shall establish whether the
Securities of a Series shall be issued in whole or in part in the form of one or more Global Securities, and the Depository for such Global Securities or Securities. 

(b)    Notwithstanding any provisions to the contrary contained in Section 2.7 and in addition thereto, if,
and only if the Depository (i) at any time is unwilling or unable to continue as Depository for such Global Security or ceases to be a clearing agency registered under the Exchange Act and (ii) a successor Depository is not appointed by
the Company within 90 days after the date the Company is so informed in writing or becomes aware of the same, the Company promptly will execute and deliver to the Trustee definitive Securities, and the Trustee, upon receipt of a Company Request for
the authentication and delivery of such definitive Securities (which the Company will promptly execute and deliver to the Trustee) and an Officers’ Certificate to the effect that such Global Security shall be so exchangeable, will authenticate
and deliver definitive Securities, without charge, registered in such names and in such authorized denominations as the Depository shall direct in writing (pursuant to instructions from its direct and indirect participants or otherwise) in an
aggregate principal amount equal to the principal amount of the Global Security with like tenor and terms. Upon the exchange of a Global Security for definitive Securities, such Global Security shall be canceled by the Trustee. Unless and until it
is exchanged in whole or in part for definitive Securities, as provided in this Section 2.15(b), a Global Security may not be transferred except as a whole by the Depository with respect to such Global Security to a nominee of such
Depository, by a nominee of such Depository to such Depository or another nominee of such Depository or by the Depository or any such nominee to a successor Depository or a nominee of such a successor Depository. 

(c)    Any Global Security issued hereunder shall bear a legend in substantially the following form: 

“This Security is a Global Security within the meaning of the Indenture hereinafter referred to, and is registered in the name of the
Depository or a nominee of the Depository. This Security is exchangeable for Securities registered in the name of a Person other than the Depository or its nominee only in the limited circumstances described in the Indenture, and may not be
transferred except as a whole by the Depository to a nominee of the Depository, by a nominee of the Depository to the Depository or another nominee of the Depository or by the Depository or any such nominee to a successor Depository or a nominee of
such a successor Depository.” 

  
 15 

 (d)    The Depository, as a Holder, may appoint agents and otherwise
authorize participants to give or take any request, demand, authorization, direction, notice, consent, waiver or other action which a Holder is entitled to give or take under the Indenture. 

(e)    Notwithstanding the other provisions of this Indenture, unless otherwise specified as contemplated by
Section 2.2, payment of the principal of, and interest and premium, if any, on, any Global Security shall be made to the Depository or its nominee in its capacity as the Holder thereof. 

(f)    Except as provided in Section 2.15(e) above, the Company, the Trustee and any Agent shall treat a
Person as the Holder of such principal amount of outstanding Securities of any Series represented by a Global Security as shall be specified in a written statement of the Depository (which may be in the form of a participants’ list for
such Series) with respect to such Global Security, for purposes of obtaining any consents, declarations, waivers or directions required to be given by the Holders pursuant to this Indenture, PROVIDED, that until the Trustee is so provided with a
written statement, it may treat the Depository or any other Person in whose name a Global Security is registered as the owner of such Global Security for the purpose of receiving payment of the principal of, and any premium and (subject to
Section 2.13) any interest on, such Global Security and for all other purposes whatsoever, and none of the Company, the Trustee or any agent of the Company or the Trustee shall be affected by notice to the contrary. 

2.16    Persons Deemed Owners. 

Prior to due presentment of a Security for registration of transfer, the Company, the Trustee, the Registrar and any agent of the Company, the
Registrar or the Trustee may treat the Person in whose name such Security is registered as the owner of such Security for the purpose of receiving payment of the principal of, and any premium and (subject to Section 2.13) any interest
on, such Security and for all other purposes whatsoever, and none of the Company, the Trustee, the Registrar or any agent of the Company, the Trustee or the Registrar shall be affected by notice to the contrary. 

ARTICLE 3 
 REDEMPTION

 3.1    Notices to Trustee. 

The Company may, with respect to any Series of Securities, reserve the right to redeem and pay the Series of Securities, or may
covenant to redeem and pay the Series of Securities or any part thereof, prior to the Stated Maturity thereof at such time and on such terms as provided for in such Securities or the related Board Resolution, supplemental indenture or
Officers’ Certificate. If a Series of Securities is redeemable and the Company elects to redeem all or part of such Series of Securities, it shall notify the Trustee of the Redemption Date and the principal amount of Securities to be
redeemed at least 45 days (unless a shorter notice shall be satisfactory to the Trustee) before the Redemption Date. Any such notice may be canceled at any time prior to notice of such redemption being mailed to any Holder, and shall thereby be void
and of no effect. 

  
 16 

 3.2    Selection by Trustee of Securities to be Redeemed. 

Unless otherwise indicated for a particular Series of Securities by a Board Resolution, a supplemental indenture or an Officers’
Certificate, if fewer than all of the Securities of a Series are to be redeemed, the Trustee shall select the Securities of a Series to be redeemed pro rata, by lot or by any other method that the Trustee considers fair and appropriate
(unless the Company specifically directs the Trustee otherwise) and, if such Securities are listed on any securities exchange, by a method that complies with the requirements of such exchange. 

The Trustee shall make the selection from Securities of a Series outstanding and not previously called for redemption, and shall promptly
notify the Company in writing of the Securities selected for redemption and, in the case of any Security selected for partial redemption, the principal amount thereof to be redeemed at least 35 but not more than 60 days before the Redemption Date.
Securities of a Series in denominations of $1,000 may be redeemed only in whole. The Trustee may select for redemption portions of the principal of Securities of a Series that have denominations larger than $1,000. Securities of a
Series and portions of them it selects shall be in amounts of $1,000 or, with respect to Securities of any Series issuable in other denominations pursuant to Section 2.2(10), the minimum principal denomination for each
Series and integral multiples thereof. Provisions of this Indenture that apply to Securities called for redemption also apply to portions of Securities called for redemption. 

3.3    Notice of Redemption. 

Unless otherwise indicated for a particular Series by Board Resolution, a supplemental indenture hereto or an Officers’ Certificate,
at least 30 days, and no more than 60 days, before a Redemption Date, the Company shall mail, or cause to be mailed, a notice of redemption by first-class mail to each Holder of Securities to be redeemed at his or her last address as the same
appears on the registry books maintained by the Registrar. The notice shall identify the Securities to be redeemed and shall state: 

(1)    the Redemption Date; 

(2)    the redemption price, and that such redemption price shall become due and payable on the Redemption Date; 

(3)    if any Security of a Series is being redeemed in part, the portion of the principal amount of such Security of
a Series to be redeemed and that, after the Redemption Date and upon surrender of such Security of a Series, a new Security or Securities in principal amount equal to the unredeemed portion will be issued; 

(4)    the name and address of the Paying Agent; 

(5)    that Securities of a Series called for redemption must be surrendered to the Paying Agent to collect the
redemption price, and the place or places where each such Security is to be surrendered for such payment; 

(6)    that, unless the Company defaults in making the redemption payment, interest on the Securities of a
Series called for redemption ceases to accrue on the Redemption Date, and the only remaining right of the Holders of such Securities is to receive payment of the redemption price upon surrender to the Paying Agent of the Securities redeemed;

  
 17 

 (7)    if fewer than all of the Securities of a Series are to be
redeemed, the identification of the particular Securities of a Series (or portion thereof) to be redeemed, as well as the aggregate principal amount of Securities of a Series to be redeemed and the aggregate principal amount of Securities
of a Series to be outstanding after such partial redemption. 
 (8)    the CUSIP number, if any, printed on the
Securities being redeemed; and 
 (9)    that no representation is made as to the correctness or accuracy of the CUSIP
number, if any, listed in such notice or printed on the Securities. 
 At the Company’s request, the Trustee shall give the notice of
redemption in the Company’s name and at the Company’s sole expense. 
 3.4    Effect of Notice of
Redemption. 
 Once the notice of redemption described in Section 3.3 is mailed, Securities of a Series called for
redemption become due and payable on the Redemption Date and at the redemption price, plus interest, if any, accrued to the Redemption Date. Upon surrender to the Trustee or Paying Agent, such Securities of a Series shall be paid at the
redemption price, plus accrued interest, if any, to the Redemption Date; PROVIDED, that if the Redemption Date is after a regular interest payment record date and on or prior to the next Interest Payment Date, the accrued interest shall be payable
to the Holder of the redeemed Securities registered on the relevant record date, as specified by the Company in the notice to the Trustee pursuant to Section 3.1. 

3.5    Deposit of Redemption Price. 

On or prior to the Redemption Date (but no later than 11:00 A.M. Eastern Time on such date), the Company shall deposit with the Paying
Agent money sufficient to pay the redemption price of and accrued interest, if any, on all Securities to be redeemed on that date other than Securities or portions thereof called for redemption on that date which have been delivered by the Company
to the Trustee for cancellation. 
 On and after any Redemption Date, if money sufficient to pay the redemption price of, and accrued
interest on, Securities called for redemption shall have been made available in accordance with the preceding paragraph and the Company and the Paying Agent are not prohibited from paying such moneys to Holders, the Securities called for redemption
will cease to accrue interest and the only right of the Holders of such Securities will be to receive payment of the redemption price of and, subject to the proviso in Section 3.4, accrued and unpaid interest on such Securities to the
Redemption Date. If any Security called for redemption shall not be so paid, interest will be paid, from the Redemption Date until such redemption payment is made, on the unpaid principal of the Security and any interest or premium, if any, not paid
on such unpaid principal, in each case, at the rate and in the manner provided in the Securities. 

  
 18 

 3.6    Securities Redeemed in Part. 

Upon surrender of a Security of a Series that is redeemed in part, the Company shall execute, and the Trustee shall authenticate, for a
Holder a new Security of the same Series equal in principal amount to the unredeemed portion of the Security surrendered. 
 ARTICLE
4 
 COVENANTS 

4.1    Payment of Securities. 

The Company shall pay the principal of, and interest and premium, if any, on, each Series of Securities on the dates and in the manner
provided in such Securities and this Indenture. 
 An installment of principal or interest shall be considered paid on the date it is due if
the Trustee or Paying Agent holds on that date money designated for and sufficient to pay such installment and is not prohibited from paying such money to the Holders pursuant to the terms of this Indenture or otherwise. 

The Company shall pay interest on overdue principal, and overdue interest, to the extent lawful, at the rate specified in the Series of
Securities. 
 4.2    SEC REPORTS. 

The Company will deliver to the Trustee within 15 days after the filing of the same with the SEC, copies of the quarterly and annual reports
and of the information, documents and other reports, if any, which the Company is required to file with the SEC pursuant to Section 13 or 15(d) of the Exchange Act; PROVIDED, HOWEVER, that each such report or document will be deemed to be
so delivered to the Trustee if the Company files such report or document with the SEC through the SEC’s EDGAR database no later than the time such report or document is required to be filed with the SEC pursuant to the Exchange Act.
Notwithstanding that the Company may not be subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act, the Company will file with the SEC, to the extent permitted, and provide the Trustee with, such quarterly and
annual reports and such information, documents and other reports specified in Sections 13 and 15(d) of the Exchange Act. The Company will also comply with the other provisions of TIA Section 314(a). 

4.3    Waiver of Stay, Extension or Usury Laws. 

The Company covenants (to the extent that it may lawfully do so) that it will not at any time insist upon, or plead (as a defense or
otherwise) or in any manner whatsoever claim or take the benefit or advantage of, any stay, extension, usury or other law which would prohibit or forgive the Company from paying all or any portion of the principal of, and/or interest and premium, if
any, on, the Securities as contemplated herein, wherever enacted, now or at any time hereafter in force, or which may affect the covenants or the performance of this Indenture; and the Company hereby expressly waives (to the extent that they may
lawfully do so) all benefit or advantage of any such law, and covenants that it will not hinder, delay or impede the execution of any power herein granted to the Trustee, but will suffer and permit the execution of every such power as though no such
law had been enacted. 

  
 19 

 4.4    Compliance Certificate. 

(a)    The Company shall deliver to the Trustee, within 120 days after the end of each fiscal year of the Company, an
Officers’ Certificate which complies with TIA Section 314(a)(4) stating that a review of the activities of the Company and its Subsidiaries during such fiscal year has been made under the supervision of the signing Officers with a
view to determining whether the Company has kept, observed, performed and fulfilled its obligations under this Indenture, and further stating, as to each such Officer signing such certificate, that to the best of his or her knowledge the Company has
kept, observed, performed and fulfilled each and every covenant contained in this Indenture and that there is no default in the performance or observance of any of the terms, provisions and conditions hereof (or, if a Default or Event of Default
shall have occurred, describing all such Defaults or Events of Default of which he or she may have knowledge and what action the Company is taking or proposes to take with respect thereto) and that to the best of his or her knowledge no event has
occurred and remains in existence by reason of which payments on account of the principal of, or interest or premium, if any, on, the Securities is prohibited, or if such event has occurred, a description of the event and what action the Company is
taking or proposes to take with respect thereto. 
 (b)    (i) If any Default or Event of Default has occurred and
is continuing or (ii) if any Holder seeks to exercise any remedy hereunder with respect to a claimed Default under this Indenture or the Securities, within five Business Days after the Company becoming aware of such occurrence the Company shall
deliver to the Trustee an Officers’ Certificate specifying such event, notice or other action and what action the Company is taking or proposes to take with respect thereto. 

4.5    Corporate Existence. 

Subject to ARTICLE 5, the Company shall do or cause to be done all things necessary to preserve and keep in full force and effect
its corporate existence, in accordance with the organizational documents (as the same may be amended from time to time) of the Company and the rights (charter and statutory), licenses and franchises of the Company; PROVIDED, HOWEVER, that the
Company shall not be required to preserve any such right, license or franchise, or its corporate existence, if the Board of Directors shall determine that the preservation thereof is no longer desirable in the conduct of the business of the Company
and that the loss thereof is not adverse in any material respect to the Holders. 
 ARTICLE 5 

SUCCESSOR CORPORATION 

5.1    Limitation on Consolidation, Merger and Sale of Assets. 

(a)    The Company will not, in any transaction or series of transactions, merge or consolidate with or into, or sell,
assign, convey, transfer, lease or otherwise dispose of all or substantially all of its properties and assets (as an entirety or substantially as an entirety in one transaction or a series of related transactions), to any Person or Persons, unless
at the time of and after giving effect thereto (i) either (A) if the transaction or series of transactions is a merger or consolidation, the Company shall be the surviving Person of such merger or consolidation, or (B) the Person
formed by such consolidation or into which the Company is merged or to which the properties and assets of the Company are transferred (any such surviving Person or transferee Person being the “Surviving Entity”) shall be a
corporation organized and existing under the laws of the United States of America, any state thereof or the District of Columbia, or a corporation or comparable legal entity organized under the laws of a foreign jurisdiction and shall expressly
assume by a supplemental indenture executed and delivered to the Trustee, in form reasonably satisfactory to the Trustee, all of the obligations of the Company (including, without limitation, the obligation to pay the principal of, and premium and
interest, if any, on, the Securities and the performance of the other covenants) under the Securities of each Series and this Indenture, and in each case, this Indenture shall remain in full force and effect; and (ii) immediately before
and immediately after giving effect to such transaction or series of transactions on a pro forma basis (including, without limitation, any Indebtedness incurred or anticipated to be incurred in connection with or in respect of such transaction or
series of transactions), no Default or Event of Default shall have occurred and be continuing. 

  
 20 

 (b)    In connection with any consolidation, merger or transfer of
assets contemplated by this Section 5.1, the Company shall deliver, or cause to be delivered, to the Trustee, in form and substance reasonably satisfactory to the Trustee, an Officers’ Certificate and an Opinion of Counsel, each
stating that such consolidation, merger or transfer, and the supplemental indenture in respect thereto, comply with this Section 5.1, and that all conditions precedent herein provided for relating to such transaction or transactions have
been complied with. 
 5.2    Successor Person Substituted. 

Upon any consolidation, merger or transfer of all or substantially all of the assets of the Company in accordance with Section 5.1 above,
the successor corporation formed by such consolidation, or into which the Company is merged or to which such transfer is made, shall succeed to, and be substituted for, and may exercise every right and power of, the Company under this Indenture with
the same effect as if such successor corporation had been named as the Company herein, and thereafter (except with respect to any such transfer which is a lease) the predecessor corporation shall be relieved of all obligations and covenants under
this Indenture and the Securities. 
 ARTICLE 6 

DEFAULTS AND REMEDIES 

6.1    Events of Default. 

“Events of Default,” wherever used herein with respect to Securities of any Series, means any one of the following events,
unless in the establishing Board Resolution, supplemental indenture or Officers’ Certificate, it is provided that such Series shall not have the benefit of said Event of Default: 

  
 21 

 (1)    there is a default in the payment of any principal of, or
premium, if any, on, the Securities when the same becomes due and payable at Maturity, upon acceleration, redemption or otherwise; 

(2)    there is a default in the payment of any interest on any Security of a Series when the same becomes due and
payable, and the Default continues for a period of 30 days; 
 (3)    the Company defaults in the observance or
performance of any other covenant in the Securities of a Series or in this Indenture for 60 days after written notice from the Trustee or the Holders of not less than 25% in the aggregate principal amount of the Securities of such
Series then outstanding, which notice must specify the Default, demand that it be remedied and state that the notice is a “Notice of Default”; 

(4)    the Company or any Significant Subsidiary pursuant to or within the meaning of any Bankruptcy Law: 

(A)    commences a voluntary case, 

(B)    consents to the entry of an order for relief against it in an involuntary case, 

(C)    consents to the appointment of a Custodian of it or for all or substantially all of its property, 

(D)    makes a general assignment for the benefit of its creditors, or 

(E)    generally is not paying its debts as they become due; 

(5)    a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: 

(A)    is for relief against the Company or any Significant Subsidiary in an involuntary case; 

(B)    appoints a Custodian of the Company or any Significant Subsidiary, or for all or substantially all of the property
of the Company or any Significant Subsidiary; or 
 (C)    orders the liquidation of the Company or any Significant
Subsidiary, and the order or decree remains unstayed and in effect for 90 consecutive days; or 
 (6)    any other Event
of Default provided with respect to Securities of that Series, which is specified in a Board Resolution, a supplemental indenture hereto or an Officers’ Certificate, in accordance with Section 2.2(19). 

  
 22 

 The term “Bankruptcy Law” means Title 11, U.S. Code, or any similar federal
or state law for the relief of debtors. The term “Custodian” means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law. 

The Trustee may withhold notice of any Default (except in the payment of the principal of, or interest or premium, if any, on, the Securities)
to the Holders of the Securities of any Series in accordance with Section 7.5. When a Default is cured, it ceases to exist. 

6.2    Acceleration. 

If an Event of Default with respect to Securities of any Series at the time outstanding (other than an Event of Default arising under
Section 6.1(4) or 6.1(5)) occurs and is continuing, the Trustee by written notice to the Company, or the Holders of not less than 25% in aggregate principal amount of the Securities of that Series then
outstanding by written notice to the Company and the Trustee, may declare that the entire principal amount of all the Securities of that Series then outstanding plus accrued and unpaid interest to the date of acceleration are immediately due
and payable, in which case such amounts shall become immediately due and payable; PROVIDED, HOWEVER, that after such acceleration but before a judgment or decree based on such acceleration is obtained by the Trustee, the Holders of a majority in
aggregate principal amount of the outstanding Securities of that Series may rescind and annul such acceleration and its consequences if (i) all existing Events of Default, other than the nonpayment of accelerated principal, interest or
premium, if any, that has become due solely because of the acceleration, have been cured or waived, (ii) to the extent the payment of such interest is lawful, interest on overdue installments of interest and overdue principal, which has become
due otherwise than by such declaration of acceleration, has been paid and (iii) the rescission would not conflict with any judgment or decree. No such rescission shall affect any subsequent Default or impair any right consequent thereto. In
case an Event of Default specified in Section 6.1(4) or 6.1(5) with respect to the Company occurs, such principal, premium, if any, and interest amount with respect to all of the Securities of that Series shall
be due and payable immediately without any declaration or other act on the part of the Trustee or the Holders of the Securities of that Series. 

6.3    Remedies. 

If an Event of Default with respect to Securities of any Series at the time outstanding occurs and is continuing, the Trustee may pursue
any available remedy by proceeding at law or in equity to collect the payment of the principal of, or interest and premium, if any, on, the Securities of that Series, or to enforce the performance of any provision of the Securities of that
Series or this Indenture. 
 The Trustee may maintain a proceeding even if it does not possess any of the Securities of that
Series or does not produce any of them in the proceeding. A delay or omission by the Trustee or any Securityholder in exercising any right or remedy accruing upon an Event of Default shall not impair the right or remedy or constitute a waiver
of or acquiescence in the Event of Default. No remedy is exclusive of any other remedy. All available remedies are cumulative to the extent permitted by law. 

  
 23 

 6.4    Waiver of Past Defaults and Events of Default. 

Subject to Sections 6.2, 6.7 and 8.2, the Holders of a majority in principal amount of the Securities of any
Series then outstanding have the right to waive any existing Default or Event of Default with respect to such Series or compliance with any provision of this Indenture (with respect to such Series) or the Securities of such Series. Upon
any such waiver, such Default with respect to such Series shall cease to exist, and any Event of Default with respect to such Series arising therefrom shall be deemed to have been cured for every purpose of this Indenture; but no such
waiver shall extend to any subsequent or other Default or Event of Default or impair any right consequent thereto. This Section 6.4 shall be in lieu of TIA Section 316(a)(1)(B), and TIA Section 316(a)(1)(B) is hereby expressly
excluded from this Indenture and Section as permitted by the TIA. 
 6.5    Control by Majority. 

Subject to Sections 6.2, 6.7 and 8.2, the Holders of a majority in principal amount of the Securities of any
Series then outstanding may direct the time, method and place of conducting any proceeding for any remedy available to the Trustee or exercising any trust or power conferred on the Trustee by this Indenture with respect to such Series. The
Trustee, however, may refuse to follow any direction that conflicts with law or this Indenture, or that the Trustee determines may be unduly prejudicial to the rights of another Securityholder, or that may involve the Trustee in personal liability;
PROVIDED, that the Trustee may take any other action deemed proper by the Trustee which is not inconsistent with such direction. This Section 6.5 shall be in lieu of TIA Section 316(a)(1)(A), and TIA
Section 316(a)(1)(A) is hereby expressly excluded from this Indenture and Section as permitted by the TIA. 

6.6    Limitation on Suits. 

Subject to Section 6.7, a Securityholder may not institute any proceeding or pursue any remedy with respect to this
Indenture or the Securities of a Series unless: 
 (1)    the Holder gives to the Trustee written notice of a
continuing Event of Default with respect to the Securities of that Series; 
 (2)    the Holders of at least 25% in
aggregate principal amount of the Securities of such Series then outstanding make a written request to the Trustee to pursue the remedy; 

(3)    such Holder or Holders offer to the Trustee indemnity reasonably satisfactory to the Trustee against any loss,
liability or expense to be incurred in compliance with such request; 
 (4)    the Trustee does not comply with the
request within 60 days after receipt of the request and the offer of indemnity; and 
 (5)    no direction inconsistent
with such written request has been given to the Trustee during such 60-day period by the Holders of a majority in aggregate principal amount of the Securities of such Series then outstanding. 

  
 24 

 A Securityholder may not use this Indenture to prejudice the rights of another
Securityholder, or to obtain a preference or priority over another Securityholder. 
 6.7    Rights of Holders to
Receive Payment. 
 Notwithstanding any other provision of this Indenture, the right of any Holder of a Security of a Series to
receive payment of the principal of, and interest and premium, if any, on, the Security of such Series on or after the respective due dates expressed in the Security of such Series, or to bring suit for the enforcement of any such payment on or
after such respective dates, is absolute and unconditional, and shall not be impaired or affected without the consent of the Holder. 

6.8    Collection Suit by Trustee. 

If an Event of Default in payment of principal, interest or premium, if any, specified in Section 6.1(1) or
6.1(2) with respect to Securities of any Series at the time outstanding occurs and is continuing, the Trustee may recover judgment in its own name and as trustee of an express trust against the Company (or any other obligor on the
Securities of that Series) for the whole amount of unpaid principal and premium, if any, and accrued interest remaining unpaid, together with interest on overdue principal and premium, if any, and, to the extent that payment of such interest is
lawful, interest on overdue installments of interest, in each case at the rate then borne by the Securities of that Series, and such further amounts as shall be sufficient to cover the costs and expenses of collection, including the reasonable
compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, as set forth in Section 7.7. 

6.9    Trustee May File Proofs of Claim. 

The Trustee may file such proofs of claim and other papers or documents, and take other actions (including sitting on a committee of
creditors), as may be necessary or advisable in order to have the claims of the Trustee (including any claim for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel) and the Securityholders
allowed in any judicial proceedings relative to the Company (or any other obligor on the Securities), any of their respective creditors or any of their respective property, and the Trustee shall be entitled and empowered to collect and receive any
monies or other property payable or deliverable on any such claims, and to distribute the same after deduction of its charges and expenses to the extent that any such charges and expenses are not paid out of the estate in any such proceedings, and
any custodian in any such judicial proceeding is hereby authorized by each Securityholder to make such payments to the Trustee, and in the event that the Trustee shall consent to the making of such payments directly to the Securityholders, to pay to
the Trustee any amount due to it for the reasonable compensation, expenses, disbursements and advances of the Trustee, its agents and counsel, and any other amounts due the Trustee under Section 7.7. 

Nothing herein contained shall be deemed to authorize the Trustee to authorize or consent to, or accept or adopt on behalf of any
Securityholder, any plan of reorganization, arrangement, adjustment or composition affecting the Securities of a Series or the rights of any Holder thereof, or to authorize the Trustee to vote in respect of the claim of any Securityholder in
any such proceedings. 

  
 25 

 6.10    Priorities. 

If the Trustee collects any money pursuant to this ARTICLE 6, it shall pay out the money in the following order:

 FIRST: to the Trustee for amounts due under Section 7.7; 

SECOND: to Securityholders for amounts then due and unpaid for the principal of, and interest and premium, if any, on, the Securities in
respect of which, or for the benefit of which, such money has been collected, ratably, without preference or priority of any kind, according to the amounts due and payable on such Securities; for principal and any premium and interest, respectively;
and 
 THIRD: to the Company. 

The Trustee may fix a record date and payment date for any payment to Securityholders pursuant to this Section 6.10.
At least 15 days before such record date, the Trustee shall mail to each Securityholder a notice that states the record date, the payment date and amount to be paid. 

6.11    Undertaking for Costs. 

In any suit for the enforcement of any right or remedy under this Indenture, or in any suit against the Trustee for any action taken or
omitted by it as Trustee, a court in its discretion may require the filing by any party litigant in the suit of an undertaking to pay the costs of the suit, and the court in its discretion may assess reasonable costs, including reasonable
attorneys’ fees, against any party litigant in the suit, having due regard to the merits and good faith of the claims or defenses made by the party litigant. This Section 6.11 does not apply to a suit by the Trustee, a
suit by a Holder pursuant to Section 6.7 or a suit by Holders of more than 10% in principal amount of the Securities of a Series then outstanding. 

ARTICLE 7 
 TRUSTEE

 7.1    Duties of Trustee. 

(a)    If an Event of Default has occurred and is continuing, the Trustee shall exercise such of the rights and powers
vested in it by this Indenture and use the same degree of care and skill in their exercise as a prudent Person would exercise or use under the same circumstances in the conduct of his own affairs. 

(b)    Except during the continuance of an Event of Default: 

(1)    The Trustee need perform only those duties that are specifically set forth in this Indenture, and no covenants or
obligations shall be implied in this Indenture against the Trustee. 

  
 26 

 (2)    In the absence of bad faith on its part, the Trustee may
conclusively rely, as to the truth of the statements and the correctness of the opinions expressed therein, upon certificates or opinions furnished to the Trustee and conforming to the requirements of this Indenture, but, in the case of any such
certificates or opinions which by any provision hereof are specifically required to be furnished to the Trustee, the Trustee shall be under a duty to examine the same to determine whether or not they conform to the requirements of this Indenture.

 (c)    The Trustee may not be relieved from liability for its own negligent action, its own negligent failure to act
or its own willful misconduct, except that: 
 (3)    This paragraph does not limit the effect of paragraph (b) of
this Section 7.1. 
 (4)    The Trustee shall not be liable for any error of judgment made in good faith by
a Responsible Officer, unless it is proved that the Trustee was negligent in ascertaining the pertinent facts. 

(5)    The Trustee shall not be liable with respect to any action it takes or omits to take in good faith in accordance
with a direction received by it pursuant to Sections 6.2 and 6.5. 
 (d)    No provision of this
Indenture shall require the Trustee to expend or risk its own funds, or otherwise incur any financial liability, in the performance of any of its rights or powers if it shall have reasonable grounds for believing that repayment of such funds or
adequate indemnity satisfactory to it against such risk or liability is not reasonably assured to it. 
 (e)    Whether
or not therein expressly so provided, paragraphs (a), (b), (c) and (d) of this Section 7.1 shall govern every provision of this Indenture that in any way relates to the Trustee. 

(f)    The Trustee and Paying Agent shall not be liable for interest on any money received by either of them, except as
the Trustee and Paying Agent may agree in writing with the Company. Money held in trust by the Trustee need not be segregated from other funds except to the extent required by the law. 

(g)    The Paying Agent, the Registrar and any authenticating agent shall be entitled to the protections, immunities and
standard of care set forth in paragraphs (a), (b), (c), (d) and (f) of this Sections 7.1 and in 7.2 with respect to the Trustee. 

7.2    Rights of Trustee. 

(a)    Subject to Section 7.1: 

(1)    The Trustee may rely on, and shall be protected in acting or refraining from acting upon, any document reasonably
believed by it to be genuine and to have been signed or presented by the proper Person. The Trustee need not investigate any fact or matter stated in the document. 

  
 27 

 (2)    Before the Trustee acts or refrains from acting, it may require
an Officers’ Certificate or an Opinion of Counsel, or both, which shall conform to the provisions of Section 10.5. The Trustee shall be protected and shall not be liable for any action it takes or omits to take in good faith in
reliance on such certificate or opinion. 
 (3)    The Trustee may act through agents and attorneys, and shall not be
responsible for the misconduct or negligence of any agent appointed by it with due care. 
 (4)    The Trustee shall
not be liable for any action it takes or omits to take in good faith which it reasonably believes to be authorized or within its rights or powers. 

(5)    The Trustee may consult with counsel reasonably acceptable to the Trustee, which may be counsel to the Company,
and the advice or opinion of such counsel as to matters of law shall be full and complete authorization and protection from liability in respect of any action taken, omitted or suffered by it hereunder in good faith and in accordance with the advice
or opinion of such counsel. 
 (6)    The Trustee shall be under no obligation to exercise any of the rights or powers
vested in it by this Indenture at the request, order or direction of any of the Holders pursuant to the provisions of this Indenture, unless such Holders shall have offered to the Trustee reasonable security or indemnity against the costs, expenses
and liabilities which may be incurred therein or thereby. 
 (7)    The Trustee shall not be deemed to have knowledge
of any fact or matter (including, without limitation, a Default or Event of Default) unless such fact or matter is known to a Responsible Officer of the Trustee. 

(8)    Unless otherwise expressly provided herein or in the Securities of a Series or the related Board Resolution,
supplemental indenture or Officers’ Certificate, the Trustee shall not have any responsibility with respect to reports, notices, certificates or other documents filed with it hereunder, except to make them available for inspection, at
reasonable times, by Securityholders, it being understood that delivery of such reports, information and documents to the Trustee is for informational purposes only and the Trustee’s receipt of such shall not constitute constructive notice of
any information contained therein or determinable from information contained therein, including the Company’s compliance with any of its covenants hereunder (except as set forth in Section 4.4). 

7.3    Individual Rights Of Trustee. 

The Trustee in its individual or any other capacity may become the owner or pledgee of Securities, and may make loans to, accept deposits
from, perform services for or otherwise deal with the Company, or any Affiliate thereof, with the same rights it would have if it were not Trustee. Any Agent may do the same with like rights. The Trustee, however, shall be subject to
Sections 7.10 and 7.11. 

  
 28 

 7.4    Trustee’s Disclaimer. 

The Trustee makes no representation as to the validity or adequacy of this Indenture or the Securities (except that the Trustee represents
that it is duly authorized to execute and deliver this Indenture and authenticate the Securities and perform its obligations hereunder), and the Trustee shall not be accountable for the Company’s use of the proceeds from the sale of Securities
or any money paid to the Company pursuant to the terms of this Indenture, and the Trustee shall not be responsible for any statement in the Securities other than its certificates of authentication. 

7.5    Notice of Default. 

If a Default or an Event of Default occurs and is continuing with respect to the Securities of any Series, and if it is known to the Trustee,
the Trustee shall mail to each Securityholder of the Securities of that Series notice of the Default or the Event of Default, as the case may be, within 90 days after it occurs or, if later, after a Responsible Officer of the Trustee has
knowledge of such Default or Event of Default (except if such Default or Event of Default has been validly cured or waived before the giving of such notice). Except in the case of a Default or an Event of Default in payment of the principal of, or
interest or premium, if any, on, any Security of any Series, the Trustee may withhold the notice if and so long as the Board of Directors of the Trustee, the executive committee or any trust committee of such board and/or its Responsible Officers in
good faith determine(s) that withholding the notice is in the interests of the Securityholders of that Series. 

7.6    Reports by Trustee to Holders. 

If and to the extent required by the TIA, within 60 days after April 1 of each year, commencing the April 1 following the date of
this Indenture, the Trustee shall mail to each Securityholder a brief report dated as of such April 1 that complies with TIA Section 313(a). The Trustee also shall comply with TIA Sections 313(b) and 313(c). 

A copy of each report at the time of its mailing to Securityholders shall be filed with the SEC and any stock exchange on which the Securities
of that Series are listed. The Company shall promptly notify the Trustee when the Securities of any Series are listed on any stock exchange or any delisting thereof, and the Trustee shall comply with TIA Section 313(d). 

7.7    Compensation and Indemnity. 

The Company shall pay to the Trustee from time to time reasonable compensation for its services. The Trustee’s compensation shall not be
limited by any provision of law on compensation of a trustee of an express trust. The Company shall reimburse the Trustee within 45 days after receipt of request for all reasonable
out-of-pocket disbursements and expenses incurred or made by it in connection with its duties under this Indenture, including the reasonable compensation, disbursements
and expenses of the Trustee’s agents and counsel. 
 The Company shall indemnify the Trustee for, and hold it harmless against, any and
all loss or liability incurred by it in connection with the acceptance or performance of its duties under this Indenture including the reasonable costs and expenses of defending itself against any claim or liability in connection with the exercise
or performance of any of its powers or duties hereunder. The Trustee shall notify the Company promptly of any claim asserted against the Trustee for which it may seek indemnity. 

  
 29 

 The failure by the Trustee to so notify the Company shall not however relieve the Company of
its obligations. Notwithstanding the foregoing, the Company need not reimburse the Trustee for any expense or indemnify it against any loss or liability incurred by the Trustee through its negligence or bad faith. To secure the payment obligations
of the Company in this Section 7.7, the Trustee shall have a lien prior to the Securities of any Series on all money or property held or collected by the Trustee except such money or property held in trust to pay the
principal of, interest and premium, if any, on particular Securities of that Series. 
 When the Trustee incurs expenses or renders services
after an Event of Default specified in Section 6.1(4) or 6.1(5) occurs, the expenses and the compensation for the services are intended to constitute expenses of administration under any Bankruptcy Law. 

For purposes of this Section 7.7, the term “Trustee” shall include any trustee appointed pursuant
to this ARTICLE 7. 
 7.8    Replacement of Trustee. 

The Trustee may resign with respect to the Securities of one or more Series by so notifying the Company in writing at least 90 days in
advance of such resignation. 
 The Holders of a majority in principal amount of the outstanding Securities of any Series may remove
the Trustee with respect to that Series by notifying the removed Trustee in writing and may appoint a successor Trustee with respect to that Series with the consent of the Company, which consent shall not be unreasonably withheld. The
Company may remove the Trustee with respect to that Series at its election if: 
 (1)    the Trustee fails to comply
with, or ceases to be eligible under, Section 7.10; 
 (2)    the Trustee is adjudged a bankrupt or
an insolvent, or an order for relief is entered with respect to the Trustee, under any Bankruptcy Law; 
 (3)    a
Custodian or other public officer takes charge of the Trustee or its property; or 
 (4)    the Trustee otherwise
becomes incapable of acting. 
 (5)    If the Trustee resigns or is removed, or if a vacancy exists in the office of
Trustee, with respect to any Series of Securities for any reason, the Company shall promptly appoint, by Board Resolution, a successor Trustee. 

If a successor Trustee with respect to the Securities of one or more Series does not take office within 60 days after the retiring
Trustee resigns or is removed, the retiring Trustee, the Company or the Holders of at least 10% in principal amount of the outstanding Securities of the applicable Series may petition any court of competent jurisdiction for the appointment of a
successor Trustee. 

  
 30 

 If the Trustee with respect to the Securities of one or more Series fails to comply
with Section 7.10, any Securityholder of the applicable Series may petition any court of competent jurisdiction for the removal of the Trustee and the appointment of a successor Trustee. 

A successor Trustee shall deliver a written acceptance of its appointment to the retiring Trustee and to the Company. Immediately following
such delivery, (i) the retiring Trustee with respect to one or more Series shall, subject to its rights under Section 7.7, transfer all property held by it as Trustee with respect to such Series to the
successor Trustee, (ii) the resignation or removal of the retiring Trustee shall become effective and (iii) the successor Trustee with respect to such Series shall have all the rights, powers and duties of the Trustee under this
Indenture. A successor Trustee with respect to the Securities of one or more Series shall mail notice of its succession to each Securityholder of such Series. 

7.9    Successor Trustee by Consolidation, Merger or Conversion. 

If the Trustee, or any Agent, consolidates with, merges or converts into, or transfers all or substantially all of its corporate trust assets
to, another corporation, subject to Section 7.10, the successor corporation without any further act shall be the successor Trustee or Agent, as the case may be. 

7.10    Eligibility; Disqualification. 

This Indenture shall always have a Trustee who satisfies the requirements of TIA Sections 310(a)(1), (2) and (5) in every respect.
The Trustee (or in the case of a Trustee that is a Person included in a bank holding company system, the related bank holding company) shall have a combined capital and surplus of at least $100,000,000 as set forth in its most recent published
annual report of condition. The Trustee shall comply with TIA Section 310(b), including the provision in Section 310(b)(1). In addition, if the Trustee is a Person included in a bank holding company system, the Trustee, independently of
such bank holding company, shall meet the capital requirements of TIA Section 310(a)(2). If at any time the Trustee shall cease to be eligible in accordance with the provisions of this Section 7.10, it shall resign
immediately in the manner and with the effect specified in this ARTICLE 7. 

7.11    Preferential Collection of Claims Against Company. 

The Trustee shall comply with TIA Section 311(a), excluding any creditor relationship listed in TIA Section 311(b). A Trustee who
has resigned or been removed shall be subject to TIA Section 311(a) to the extent indicated therein. 

7.12    Paying Agents. 

The Company shall cause each Paying Agent other than the Trustee to execute and deliver to it and the Trustee an instrument in which such
agent shall agree with the Trustee, subject to the provisions of this Section 7.12: 

  
 31 

 (1)    that it will hold all sums held by it as agent for the payment of
the principal of, or interest or premium, if any, on, the Securities (whether such sums have been paid to it by the Company or by any obligor on the Securities) in trust for the benefit of Holders of the Securities or the Trustee; 

(2)    that it will at any time during the continuance of any Event of Default, upon written request from the Trustee,
deliver to the Trustee all sums so held in trust by it together with a full accounting thereof; and 
 (3)    that it
will give the Trustee written notice within three Business Days after any failure of the Company (or by any obligor on the Securities) in the payment of any installment of the principal of, or interest or premium, if any, on, the Securities when the
same shall be due and payable. 
 ARTICLE 8 

AMENDMENTS, SUPPLEMENTS AND WAIVERS 

8.1    Without Consent of Holders. 

The Company, when authorized by a Board Resolution, and the Trustee may amend or supplement this Indenture or the Securities of one or more
Series without notice to or consent of any Securityholder: 
 (1)    to comply with Section 5.1; 

(2)    to provide for certificated Securities in addition to uncertificated Securities; 

(3)    to comply with any requirements of the SEC under the TIA; 

(4)    to cure any ambiguity, defect or inconsistency, or to make any other change herein or in the Securities that does
not materially and adversely affect the rights of any Securityholder; 
 (5)    to provide for the issuance of, and
establish the form and terms and conditions of, Securities of any Series as permitted by this Indenture; or 

(6)    to evidence and provide for the acceptance of appointment hereunder by a successor Trustee with respect to the
Securities of one or more Series, and to add to or change any of the provisions of this Indenture as shall be necessary to provide for or facilitate the administration of the trusts hereunder by more than one Trustee. 

The Trustee is hereby authorized to join with the Company in the execution of any supplemental indenture authorized or permitted by the terms
of this Indenture, and to make any further appropriate agreements and stipulations which may be therein contained, but the Trustee shall not be obligated to enter into any such supplemental indenture which adversely affects its own rights, duties or
immunities under this Indenture. 

  
 32 

 8.2    With Consent of Holders. 

(a)    The Company, when authorized by a Board Resolution, and the Trustee may amend or supplement this Indenture or the
Securities of one or more Series with the written consent of the Holders of not less than a majority in aggregate principal amount of the outstanding Securities of such Series affected by such amendment or supplement without notice to any
Securityholder. The Holders of not less than a majority in aggregate principal amount of the outstanding Securities of each such Series affected by such amendment or supplement may waive compliance by the Company in a particular instance with
any provision of this Indenture or the Securities of such Series without notice to any Securityholder. Subject to Section 8.4, without the consent of each Securityholder affected, however, an amendment, supplement or waiver may not:

 (1)    reduce the amount of Securities whose Holders must consent to an amendment, supplement or waiver to this
Indenture or the Securities; 
 (2)    reduce the rate of, or change the time for payment of, interest on any Security;

 (3)    reduce the principal, or change the Stated Maturity, of any Security, or reduce the amount of, or postpone
the date fixed for, the payment of any sinking fund or analogous obligation; 
 (4)    make any Security payable in
money other than that stated in the Security; 
 (5)    change the amount or time of any payment required by the
Securities, or reduce the premium payable upon any redemption of the Securities, or change the time before which no such redemption may be made; 

(6)    waive a Default or Event of Default in the payment of the principal of, or interest or premium, if any, on, any
Security (except a rescission of acceleration of the Securities of any Series by the Holders of at least a majority in principal amount of the outstanding Securities of such Series and a waiver of the payment default that resulted from
such acceleration); 
 (7)    waive a redemption payment with respect to any Security, or change any of the provisions
with respect to the redemption of any Securities; 
 (8)    make any changes in Section 6.6 or this
Section 8.2, except to increase any percentage of Securities the Holders of which must consent to any matter; or 

(9)    take any other action otherwise prohibited by this Indenture to be taken without the consent of each Holder
affected thereby. 
 (b)    Upon the request of the Company, accompanied by a Board Resolution authorizing the execution
of any such supplemental indenture, and upon the receipt by the Trustee of evidence reasonably satisfactory to the Trustee of the consent of the Securityholders as aforesaid and of the documents described in Section 8.6, the Trustee
shall join with the Company in the execution of such supplemental indenture, unless such supplemental indenture affects the Trustee’s own rights, duties or immunities under this Indenture, in which case the Trustee may in its discretion, but
shall not be obligated to, enter into such supplemental indenture. 

  
 33 

 (c)    It shall not be necessary for the consent of the Holders under
this section to approve the particular form of any proposed amendment, supplement or waiver, but it shall be sufficient if such consent approves the substance thereof. 

After an amendment or supplement under this Section becomes effective, the Company shall mail to Securityholders a notice briefly describing
the amendment or supplement. Any failure of the Company to mail any such notice, or any defect therein, shall not, however, in any way impair or affect the validity of any supplemental indenture. 

8.3    Compliance With Trust Indenture Act. 

Every amendment to, or supplement of, this Indenture or the Securities shall comply with the TIA as then in effect. 

8.4    Revocation and Effect of Consents. 

Until an amendment, supplement, waiver or other action becomes effective, a consent to it by a Holder of a Security is a continuing consent
conclusive and binding upon such Holder and every subsequent Holder of the same Security or portion thereof, and of any Security issued upon the transfer thereof or in exchange therefor or in place thereof, even if notation of the consent is not
made on any such Security. Any such Holder or subsequent Holder, however, may revoke the consent as to his Security or portion of a Security, if the Trustee receives the notice of revocation before the date the amendment, supplement, waiver or other
action becomes effective. 
 The Company may, but shall not be obligated to, fix a record date for the purpose of determining the Holders
entitled to consent to any amendment, supplement or waiver, which record date shall be at least 30 days prior to the first solicitation of such consent. If a record date is fixed, then, notwithstanding the preceding paragraph, those Persons who were
Holders at such record date (or their duly designated proxies), and only such Persons, shall be entitled to consent to such amendment, supplement or waiver, or to revoke any consent previously given, whether or not such Persons continue to be
Holders after such record date. 
 After an amendment, supplement, waiver or other action becomes effective, it shall bind every
Securityholder, unless it makes a change described in any of clauses (1) through (9) of Section 8.2. In that case, the amendment, supplement, waiver or other action shall bind each Holder of a Security who has
consented to it and every subsequent Holder of a Security or portion of a Security that evidences the same debt as the consenting Holder’s Security; PROVIDED, that any such waiver shall not impair or affect the right of any Holder to receive
payment of the principal of, and interest and premium, if any, on, a Security, on or after the respective due dates expressed in such Security, or to bring suit for the enforcement of any such payment on or after such respective dates without the
consent of such Holder. 

  
 34 

 8.5    Notation On or Exchange of Securities. 

If an amendment, supplement or waiver changes the terms of a Security of any Series, the Trustee may request the Holder of such Security to
deliver it to the Trustee. In such case, the Trustee shall place an appropriate notation on such Security about the changed terms and return it to the Holder. Alternatively, the Company, in exchange for such Security, may issue, and the Trustee
shall authenticate, a new security that reflects the changed terms. Failure to make the appropriate notation or issue a new Security shall not affect the validity and effect of such amendment, supplement or waiver. 

8.6    Trustee To Sign Amendments, Etc. 

The Trustee shall sign any amendment, supplement or waiver authorized pursuant to this ARTICLE 8 if the amendment,
supplement or waiver does not adversely affect the rights, duties, liabilities or immunities of the Trustee. If it does, the Trustee may, but need not, sign it. In signing or refusing to sign such amendment, supplement or waiver the Trustee shall be
entitled to receive and, subject to Section 7.1, shall be fully protected in relying upon an Officers’ Certificate and an Opinion of Counsel stating that such amendment, supplement or waiver is authorized or permitted
by this Indenture. The Company may not sign an amendment or supplement until the Board of Directors of the Company approves it. 
 ARTICLE
9 
 DISCHARGE OF INDENTURE; DEFEASANCE 

9.1    Discharge of Indenture. 

The Company may terminate its obligations under the Securities of any Series and this Indenture with respect to such Series, except the
obligations referred to in the last paragraph of this Section 9.1, if there shall have been canceled by the Trustee, or delivered to the Trustee for cancellation, all Securities of such Series theretofore authenticated
and delivered (other than any Securities of such Series that are asserted to have been destroyed, lost or stolen and that shall have been replaced as provided in Section 2.8) and the Company has paid all sums payable
by it hereunder or deposited all required sums with the Trustee. 
 After such delivery the Trustee upon request shall acknowledge in a
writing prepared by or on behalf of the Company the discharge of the Company’s obligations under the Securities of such Series and this Indenture, except for those surviving obligations specified below. 

Notwithstanding the satisfaction and discharge of this Indenture, the obligations of the Company in Sections 7.7,
9.5 and 9.6 shall survive. 
 9.2    Legal Defeasance. 

The Company may at its option, by Board Resolution, be discharged from its obligations with respect to the Securities of any Series on
the date upon which the conditions set forth in Section 9.4 below are satisfied (hereinafter, “Legal Defeasance”). For this purpose, such Legal Defeasance means that the Company shall be deemed to have paid
and discharged the entire indebtedness represented by the Securities of such Series and to have satisfied all its other obligations under such Securities and this Indenture insofar as such Securities are concerned (and the Trustee, at the
expense of the Company, shall, subject to Section 9.6, execute proper instruments acknowledging the same, as are delivered to it by the Company), except for the following, which shall survive until otherwise terminated or
discharged hereunder: (A) the rights of Holders of outstanding Securities of such Series to receive solely from the trust funds described in Section 9.4 and as more fully set forth in such section, payments in
respect of the principal of, and interest and premium, if any, on, the Securities of such Series when such payments are due, (B) the Company’s obligations with respect to the Securities of such Series under
Sections 2.4, 2.5, 2.6, 2.7, 2.8 and 2.9, (C) the rights, powers, trusts, duties and immunities of the Trustee hereunder (including claims of, or payments to, the Trustee under or
pursuant to Section 7.7) and (D) this ARTICLE 9. Subject to compliance with this ARTICLE 9, the Company may exercise its option under this Section 9.2 with
respect to the Securities of any Series notwithstanding the prior exercise of its option under Section 9.3 below with respect to the Securities of such Series. 

  
 35 

 9.3    Covenant Defeasance. 

At the option of the Company, pursuant to a Board Resolution, the Company shall be released from its obligations with respect to the
outstanding Securities of any Series under Sections 4.2 through 4.5, inclusive, and Section 5.1, with respect to the outstanding Securities of such Series, on and after the date the
conditions set forth in Section 9.4 are satisfied (hereinafter, “Covenant Defeasance”). For this purpose, such Covenant Defeasance means that the Company may omit to comply with and shall have no liability
in respect of any term, condition or limitation set forth in any such specified section or portion thereof, whether directly or indirectly by reason of any reference elsewhere herein to any such specified Section or portion thereof or by reason
of any reference in any such specified section or portion thereof to any other provision herein or in any other document, but the remainder of this Indenture and the Securities of any Series shall be unaffected thereby. 

9.4    Conditions to Legal Defeasance or Covenant Defeasance. 

The following shall be the conditions to application of Section 9.2 or Section 9.3 to the
outstanding Securities of a Series: 
 (1)    the Company shall irrevocably have deposited or caused to be deposited with
the Trustee (or another trustee satisfying the requirements of Section 7.10 who shall agree to comply with the provisions of this ARTICLE 9 applicable to it) as funds in trust for the purpose of making the following payments,
specifically pledged as security for, and dedicated solely to, the benefit of the Holders of the Securities, (A) money in an amount, or (B) U.S. Government Obligations or Foreign Government Obligations which through the scheduled
payment of principal and interest in respect thereof in accordance with their terms will provide, not later than the due date of any payment, money in an amount, or (C) a combination thereof, sufficient, in the opinion of a nationally
recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, to pay and discharge, and which shall be applied by the Trustee (or other qualifying trustee) to pay and discharge, the
principal of, and accrued interest and premium, if any, on, the outstanding Securities of such Series at the Stated Maturity of such principal, interest or premium, if any, or on dates for payment and redemption of such principal,
interest and premium, if any, selected in accordance with the terms of this Indenture and of the Securities of such Series; 

  
 36 

 (2)    no Event of Default or Default with respect to the Securities of
such Series shall have occurred and be continuing on the date of such deposit, or shall have occurred and be continuing at any time during the period ending on the 91st day after the date of such deposit or, if longer, ending on the day
following the expiration of the longest preference period under any Bankruptcy Law applicable to the Company in respect of such deposit as specified in the Opinion of Counsel identified in paragraph (8) below (it being understood that this
condition shall not be deemed satisfied until the expiration of such period); 
 (3)    such Legal Defeasance or
Covenant Defeasance shall not cause the Trustee to have a conflicting interest for purposes of the TIA with respect to any securities of the Company; 

(4)    such Legal Defeasance or Covenant Defeasance shall not result in a breach or violation of, or constitute default
under, any other agreement or instrument to which the Company is a party or by which it is bound; 
 (5)    the Company
shall have delivered to the Trustee an Opinion of Counsel stating that, as a result of such Legal Defeasance or Covenant Defeasance, neither the trust nor the Trustee will be required to register as an investment company under the Investment Company
Act of 1940, as amended; 
 (6)    in the case of an election under Section 9.2, the Company shall have delivered
to the Trustee an Opinion of Counsel stating that (i) the Company has received from, or there has been published by, the Internal Revenue Service a ruling to the effect that or (ii) there has been a change in any applicable Federal income
tax law with the effect that, and such opinion shall confirm that, the Holders of the outstanding Securities of such Series or Persons in their positions will not recognize income, gain or loss for Federal income tax purposes solely as a result
of such Legal Defeasance and will be subject to Federal income tax on the same amounts, in the same manner, including as a result of prepayment, and at the same times as would have been the case if such Legal Defeasance had not occurred; 

(7)    in the case of an election under Section 9.3, the Company shall have delivered to the Trustee an Opinion of
Counsel to the effect that the Holders of the outstanding Securities of such Series will not recognize income, gain or loss for Federal income tax purposes as a result of such Covenant Defeasance, and will be subject to Federal income tax on
the same amounts, in the same manner and at the same times as would have been the case if such Covenant Defeasance had not occurred; 

(8)    the Company shall have delivered to the Trustee an Officers’ Certificate and an Opinion of Counsel, each
stating that all conditions precedent provided for in this ARTICLE 9 relating to either the Legal Defeasance under Section 9.2 or the Covenant Defeasance under Section 9.3 (as the case may be) have been complied
with; 

  
 37 

 (9)    the Company shall have delivered to the Trustee an Officers’
Certificate stating that the deposit under clause (1) was not made by the Company with the intent of defeating, hindering, delaying or defrauding any creditors of the Company or others; and 

(10)    the Company shall have paid, or duly provided for payment under terms mutually satisfactory to the Company and the
Trustee, all amounts then due to the Trustee pursuant to Section 7.7. 
  

	 	9.5	 Deposited Money And U.S. And Foreign Government Obligations To Be Held In Trust; Other Miscellaneous
Provisions. 

 All money, U.S. Government Obligations and Foreign Government Obligations (including the proceeds
thereof) deposited with the Trustee pursuant to Section 9.4 in respect of the outstanding Securities shall be held in trust and applied by the Trustee, in accordance with the provisions of such Securities and this
Indenture, to the payment, either directly or through any Paying Agent as the Trustee may determine, to the Holders of such Securities, of all sums due and to become due thereon in respect of principal, accrued interest and premium, if any, but such
money need not be segregated from other funds except to the extent required by law. 
 The Company shall pay and indemnify the Trustee
against any tax, fee or other charge imposed on or assessed against the U.S. Government Obligations and Foreign Government Obligations deposited pursuant to Section 9.4 or the principal, interest and premium, if any,
received in respect thereof other than any such tax, fee or other charge which by law is for the account of the Holders of the outstanding Securities. 

Anything in this ARTICLE 9 to the contrary notwithstanding, but subject to payment of any of its outstanding fees
and expenses, the Trustee shall deliver or pay to the Company from time to time upon Company Request any money, U.S. Government Obligations or Foreign Government Obligations held by the Trustee as provided in Section 9.4
which, in the opinion of a nationally-recognized firm of independent public accountants expressed in a written certification thereof delivered to the Trustee, are in excess of the amount thereof which would then be required to be deposited to effect
an equivalent Legal Defeasance or Covenant Defeasance. 
 9.6    Reinstatement. 

If the Trustee or Paying Agent is unable to apply any money, U.S. Government Obligations or Foreign Government Obligations in accordance with
Sections 9.1, 9.2, 9.3 or 9.4 by reason of any legal proceeding or by reason of any order or judgment of any court or governmental authority enjoining, restraining or otherwise prohibiting such application,
the Company’s obligations under this Indenture and the Securities shall be revived and reinstated as though no deposit had occurred pursuant to this ARTICLE 9 until such time as the Trustee or Paying Agent is permitted
to apply all such money, U.S. Government Obligations or Foreign Government Obligations, as the case may be, in accordance with Sections 9.1, 9.2, 9.3 or 9.4; PROVIDED, HOWEVER, that if the Company has made any
payment of principal of, or accrued interest or premium, if any, on, any Securities because of the reinstatement of its obligations, the Company shall be subrogated to the rights of the Holders of such Securities to receive such payment from the
money, U.S. Government Obligations or Foreign Government Obligations held by the Trustee or Paying Agent. 

  
 38 

 9.7    Moneys Held by Paying Agent. 

In connection with the satisfaction and discharge of this Indenture, all moneys then held by any Paying Agent under the provisions of this
Indenture shall, upon demand of the Company, be paid to the Trustee, or, if sufficient moneys have been deposited pursuant to Section 9.1, to the Company, and thereupon such Paying Agent shall be released from all further
liability with respect to such moneys. 
 9.8    Moneys Held by Trustee. 

Any moneys deposited with the Trustee or any Paying Agent or then held by the Company in trust for the payment of the principal of, or
interest or premium, if any, on, any Security that are not applied but remain unclaimed by the Holder of such Security for two years after the date upon which the principal of, or interest or premium, if any, on, such Security shall have
respectively become due and payable shall be repaid to the Company upon Company Request, or if such moneys are then held by the Company in trust, such moneys shall be released from such trust; and the Holder of such Security entitled to receive such
payment shall thereafter, as an unsecured general creditor, look only to the Company for the payment thereof, and all liability of the Trustee or such Paying Agent with respect to such trust money shall thereupon cease; PROVIDED, HOWEVER, that the
Trustee or any such Paying Agent, before being required to make any such repayment, may, at the expense of the Company, either mail to each Securityholder affected, at the address shown in the register of the Securities maintained by the Registrar,
or cause to be published once a week for two successive weeks, in a newspaper published in the English language, customarily published each Business Day and of general circulation in the City of New York, New York, a notice that such money remains
unclaimed and that, after a date specified therein, which shall not be less than 30 days from the date of such mailing or publication, any unclaimed balance of such moneys then remaining will be repaid to the Company. After payment to the Company or
the release of any money held in trust by the Company, Securityholders entitled to the money must look only to the Company for payment as general creditors, unless applicable abandoned property law designates another Person. 

ARTICLE 10 

MISCELLANEOUS 

10.1    Trust Indenture Act Controls. 

If any provision of this Indenture limits, qualifies or conflicts with another provision which is required to be included in this Indenture by
the TIA, the required provision shall control. If any provision of this Indenture modifies or excludes any provision of the TIA which may be so modified or excluded, the latter provision shall be deemed to apply to this Indenture as so modified or
to be excluded, as the case may be. 

  
 39 

 10.2    Notices. 

Any notice or communication shall be given in writing and delivered in Person, sent by facsimile (and receipt confirmed by telephone or
electronic transmission report), delivered by commercial courier service or mailed by first-class mail, postage prepaid, addressed as follows: 

If to the Company: 
 EyePoint
Pharmaceuticals, Inc. 
 480 Pleasant Street, Suite B300 

Watertown, MA 02472 
 Attn:
President and Chief Executive Officer 
 Facsimile: (617) 926-5000 

Copy to: 
 Hogan Lovells US LLP

 1735 Market Street, 23rd Floor 

Philadelphia, PA 19103-2799 
 Fax:
267-675-4601 
 Attention: Steven J. Abrams, Esq. 

If to the Trustee: 
  

                                         
            
 
                                         
            
 
                                         
            
 The Company or the Trustee by written notice to the other may
designate additional or different addresses for subsequent notices or communications. Any notice or communication to the Company or the Trustee shall be deemed to have been given or made as of the date so delivered if personally delivered; when
receipt is confirmed by telephone or electronic transmission report, if sent by facsimile; and three Business Days after mailing if sent by registered or certified mail, postage prepaid (except that a notice of change of address shall not be deemed
to have been given until actually received by the addressee). 
 Any notice or communication mailed to a Securityholder shall be mailed to
such Securityholder by first-class mail, postage prepaid, at such Securityholder’s address shown on the register kept by the Registrar. 

Failure to mail, or any defect in, a notice or communication to a Securityholder shall not affect its sufficiency with respect to other
Securityholders. If a notice or communication to a Securityholder is mailed in the manner provided above, it shall be deemed duly given, three Business Days after such mailing, whether or not the addressee receives it. 

In case by reason of the suspension of regular mail service, or by reason of any other cause, it shall be impossible to mail any notice as
required by this Indenture, then such method of notification as shall be made with the approval of the Trustee shall constitute a sufficient mailing of such notice. 

  
 40 

 In the case of Global Securities, notices or communications to be given to Securityholders
shall be given to the Depository, in accordance with its applicable policies as in effect from time to time. 
 In addition to the manner
provided for in the foregoing provisions, notices or communications to Securityholders shall be given by the Company by release made to Reuters Economic Services and Bloomberg Business News. 

10.3    Communications by Holders With Other Holders. 

Securityholders of any Series may communicate pursuant to TIA Section 312(b) with other Securityholders of that Series or
any other Series with respect to their rights under this Indenture or the Securities of that Series or any other Series. The Company, the Trustee, the Registrar and any other Person shall have the protection of TIA Section 312(c).

 10.4    Certificate and Opinion as to Conditions Precedent. 

Upon any request or application by the Company to the Trustee to take any action under this Indenture, the Company shall furnish to the
Trustee: 
 (1)    an Officers’ Certificate (which shall include the statements set forth in
Section 10.5 below) stating that, in the opinion of the signers, all conditions precedent, if any, provided for in this Indenture relating to the proposed action have been complied with; and 

(2)    an Opinion of Counsel (which shall include the statements set forth in Section 10.5 below) stating that, in
the opinion of such counsel, all such conditions precedent have been complied with. 
 10.5    Statement Required in
Certificate and Opinion. 
 Each certificate and opinion with respect to compliance with a condition or covenant provided for in this
Indenture (other than pursuant to Section 4.4) shall include: 
 (1)    a statement that the
Person making such certificate or opinion has read such covenant or condition; 
 (2)    a brief statement as to the
nature and scope of the examination or investigation upon which the statements or opinions contained in such certificate or opinion are based; 

(3)    a statement that, in the opinion of such Person, it or he has made such examination or investigation as is
necessary to enable it or him to express an informed opinion as to whether or not such covenant or condition has been complied with; and 

(4)    a statement as to whether or not, in the opinion of such Person, such covenant or condition has been complied with.

 10.6    Rules by Trustee and Agents. 

  
 41 

 The Trustee may make reasonable rules for action by or at meetings of Securityholders.
The Registrar and Paying Agent may make reasonable rules for their functions. 
 10.7    Business Days; Legal
Holidays; Place of Payment. 
 A “Business Day” is a day that is not a Legal Holiday. A “Legal
Holiday” is a Saturday, a Sunday, a federally-recognized holiday or a day on which banking institutions are not authorized or required by law, regulation or executive order to be open in the State of New York. 

If a payment date is a Legal Holiday at a Place of Payment, payment may be made at that place on the next succeeding day that is not a Legal
Holiday, and no interest shall accrue for the intervening period. “Place of Payment” means the place or places where the principal of, and interest and premium, if any, on, the Securities of a Series are payable as specified as
contemplated by Section 2.2. If the regular record date is a Legal Holiday, the record date shall not be affected. 

10.8    Governing Law. 

THIS INDENTURE AND THE SECURITIES SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, AS APPLIED TO
CONTRACTS MADE AND PERFORMED WITHIN THE STATE OF NEW YORK WITHOUT REGARD TO PRINCIPLES OF CONFLICTS OF LAW. 

10.9    No Adverse Interpretation of Other Agreements. 

This Indenture may not be used to interpret another indenture, loan, security or debt agreement of the Company or any Subsidiary thereof. No
such indenture, loan, security or debt agreement may be used to interpret this Indenture. 
 A director, officer, employee, stockholder or
incorporator, as such, of the Company shall not have any liability for any obligations of the Company under the Securities or the Indenture. Each Securityholder by accepting a Security waives and releases all such liability. Such waiver and release
are part of the consideration for the issuance of the Securities. 
 10.10    Successors. 

All covenants and agreements of the Company in this Indenture and the Securities shall bind the Company’s successors and assigns, whether
so expressed or not. All agreements of the Trustee, any additional trustee and any Paying Agents in this Indenture shall bind their respective successors and assigns. 

10.11    Multiple Counterparts. 

The parties may sign multiple counterparts of this Indenture. Each signed counterpart shall be deemed an original, but all of them together
represent one and the same agreement. 
 10.12    Table of Contents, Headings, Etc. 

  
 42 

 The table of contents, cross-reference sheet and headings of the Articles and Sections of
this Indenture have been inserted for convenience of reference only, are not to be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof. 

10.13    Severability. 

Each provision of this Indenture shall be considered separable, and if for any reason any provision which is not essential to the effectuation
of the basic purpose of this Indenture or the Securities shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby, and a Holder shall have
no claim therefor against any party hereto. 
 10.14    Securities in a Foreign Currency or in Euros. 

Unless otherwise specified in a Board Resolution, a supplemental indenture hereto or an Officers’ Certificate delivered pursuant to
Section 2.2 with respect to a particular Series of Securities, whenever for purposes of this Indenture any action may be taken by the Holders of a specified percentage in aggregate principal amount of Securities of all Series or all
Series affected by a particular action at the time outstanding and, at such time, there are outstanding Securities of any Series which are denominated in a coin or currency other than Dollars (including Euros), then the principal amount of
Securities of such Series which shall be deemed to be outstanding for the purpose of taking such action shall be that amount of Dollars that could be obtained for such amount at the Market Exchange Rate at such time. For purposes of this
Section 10.14, “Market Exchange Rate” shall mean the noon Dollar buying rate in New York City for cable transfers of that currency as published by the Federal Reserve Bank of New York; PROVIDED, HOWEVER, in the case of Euros,
Market Exchange Rate shall mean the rate of exchange determined by the Commission of the European Union (or any successor thereto) as published in the Official Journal of the European Union (such publication or any successor publication, the
“Journal”). If such Market Exchange Rate is not available for any reason with respect to such currency, the Trustee shall use, in its sole discretion and without liability on its part, such quotation of the Federal Reserve Bank of
New York or, in the case of Euros, the rate of exchange as published in the Journal, as of the most recent available date, or quotations or, in the case of Euros, rates of exchange from one or more major banks in New York City or in the country of
issue of the currency in question or, in the case of Euros, in Luxembourg or such other quotations or, in the case of Euros, rates of exchange as the Trustee, upon consultation with the Company, shall deem appropriate. The provisions of this
paragraph shall apply in determining the equivalent principal amount in respect of Securities of a Series denominated in currency other than Dollars in connection with any action taken by Holders of Securities pursuant to the terms of this
Indenture. 
 All decisions and determinations of the Trustee regarding the Market Exchange Rate or any alternative determination provided
for in the preceding paragraph shall be in the Trustee’s sole discretion, and shall, in the absence of manifest error, be conclusive to the extent permitted by law for all purposes and irrevocably binding upon the Company and all Holders. 

  
 43 

 10.15    Judgment Currency. 

The Company agrees, to the fullest extent that it may effectively do so under applicable law, that (a) if for the purpose of obtaining
judgment in any court it is necessary to convert the sum due in respect of the principal of, or interest or premium, if any, or other amount on, the Securities of any Series (the “Required Currency”) into a currency in which a
judgment will be rendered (the “Judgment Currency”), the rate of exchange used shall be the rate at which, in accordance with normal banking procedures, the Trustee could purchase in The City of New York the Required Currency with
the Judgment Currency on the day on which final unappealable judgment is entered, unless such day is not a Business Day, in which instance, the rate of exchange used shall be the rate at which, in accordance with normal banking procedures, the
Trustee could purchase in The City of New York the Required Currency with the Judgment Currency on the Business Day preceding the day on which final unappealable judgment is entered and (b) its obligations under this Indenture to make payments
in the Required Currency (i) shall not be discharged or satisfied by any tender or any recovery pursuant to any judgment (whether or not entered in accordance with subsection (a)) in any currency other than the Required Currency, except to the
extent that such tender or recovery shall result in the actual receipt, by the payee, of the full amount of the Required Currency expressed to be payable in respect of such payments, (ii) shall be enforceable as an alternative or additional
cause of action for the purpose of recovering in the Required Currency the amount, if any, by which such actual receipt shall fall short of the full amount of the Required Currency so expressed to be payable and (iii) shall not be affected by
judgment being obtained for any other sum due under this Indenture. 
 10.16    Force Majeure. 

In no event shall the Trustee be responsible or liable for any failure or delay in the performance of its obligations hereunder arising out of
or caused by, directly or indirectly, forces beyond its control, including, without limitation, strikes, work stoppages, accidents, acts of war or terrorism, civil or military disturbances, nuclear or natural catastrophes or acts of God, and
interruptions, loss or malfunctions of utilities, communications or computer (software and hardware) services, it being understood that the Trustee shall use reasonable best efforts which are consistent with accepted practices in the banking
industry to resume performance as soon as practicable under the circumstances. 
 10.17    U.S.A. Patriot Act.

 The parties hereto acknowledge that in accordance with Section 326 of the U.S.A. Patriot Act, the Trustee is required to obtain,
verify, and record information that identifies each person or legal entity that establishes a relationship or opens an account with the Trustee. The parties to this Indenture agree that they will provide the Trustee with such information as it may
request in order for the Trustee to satisfy the requirements of the U.S.A. Patriot Act. 

  
 44 

 ARTICLE 11 

SINKING FUNDS 

11.1    Applicability of Article. 

The provisions of this Article shall be applicable to any sinking fund for the retirement of the Securities of a Series if so
provided by the terms of such Securities pursuant to Section 2.2 and except as otherwise permitted or required by any form of Security of such Series issued pursuant to this Indenture. The minimum amount of any sinking fund payment
provided for by the terms of the Securities of any Series is herein referred to as a “mandatory sinking fund payment” and any other amount provided for by the terms of Securities of such Series is herein referred to as a
“optional sinking fund payment.” If provided for by the terms of Securities of any Series, the cash amount of any sinking fund payment may be subject to reduction as provided in Section 11.2. Each sinking fund payment shall be applied
to the redemption of Securities of any Series as provided for by the terms of the Securities of such Series. 

11.2    Satisfaction of Sinking Fund Payments with Securities. 

The Company may, in satisfaction of all or any part of any sinking fund payment with respect to the Securities of any Series to be made
pursuant to the terms of such Securities (1) deliver outstanding Securities of such Series to which such sinking fund payment is applicable (other than any of such Securities previously called for mandatory sinking fund redemption) and
(2) apply as credit Securities of such Series to which such sinking fund payment is applicable and which have been repurchased by the Company or redeemed either at the election of the Company pursuant to the terms of such Series of
Securities (except pursuant to any mandatory sinking fund) or through the application of permitted optional sinking fund payments or other optional redemptions pursuant to the terms of such Securities, provided that such Securities have not been
previously so credited. Such Securities shall be received by the Trustee, together with an Officers’ Certificate with respect thereto, not later than 15 days prior to the date on which the Trustee begins the process of selecting Securities for
redemption, and shall be credited for such purpose by the Trustee at the price specified in such Securities for redemption through operation of the sinking fund and the amount of such sinking fund payment shall be reduced accordingly. If as a result
of the delivery or credit of Securities in lieu of cash payments pursuant to this Section 11.2, the principal amount of Securities of such Series to be redeemed in order to exhaust the aforesaid cash payment shall be less than $100,000,
the Trustee need not call Securities of such Series for redemption, except upon receipt of a Company Order that such action be taken, and such cash payment shall be held by the Trustee or a Paying Agent and applied to the next succeeding
sinking fund payment, provided, however, that the Trustee or such Paying Agent shall from time to time upon receipt of a Company Order pay over and deliver to the Company any cash payment so being held by the Trustee or such Paying Agent upon
delivery by the Company to the Trustee of Securities of that Series purchased by the Company having an unpaid principal amount equal to the cash payment required to be released to the Company. 

11.3    Redemption of Securities for Sinking Fund. 

Not less than 45 days (unless otherwise indicated in the Board Resolution, supplemental indenture hereto or Officers’ Certificate in
respect of a particular Series of Securities) prior to each sinking fund payment date for any Series of Securities, the Company will deliver to the Trustee an Officers’ Certificate specifying the amount of the next ensuing mandatory
sinking fund payment for that Series pursuant to the terms of that Series, the portion thereof, if any, which is to be satisfied by payment of cash and the portion thereof, if any, which is to be satisfied by delivering and crediting of
Securities of that Series pursuant to Section 11.2, and the optional amount, if any, to be added in cash to the next ensuing mandatory sinking fund payment, and the Company shall thereupon be obligated to pay the amount therein specified.
Not less than 30 days (unless otherwise indicated in the Board Resolution, Officers’ Certificate or supplemental indenture in respect of a particular Series of Securities) before each such sinking fund payment date the Securities to be
redeemed upon such sinking fund payment date will be selected in the manner specified in Section 3.2 and the Company shall send or cause to be sent a notice of the redemption thereof to be given in the name of and at the expense of the Company
in the manner provided in and in accordance with Section 3.3. Such notice having been duly given, the redemption of such Securities shall be made upon the terms and in the manner stated in Sections 3.4, 3.5 and 3.6. 

  
 45 

 IN WITNESS WHEREOF, the parties hereto have caused this Indenture to be duly executed, and
their respective corporate seals to be hereunto affixed and attested, all as of the day and year first above written. 
  

			
	EYEPOINT PHARMACEUTICALS, INC..

 
			
		
	 By:
	 	  

 
			
	 Name:
	 	  

 
			
	 Title:
	 	  

 
			
	
	[Name of Trustee]

 
			
		
	 By:
	 	  

 
			
	 Name:
	 	  

 
			
	 Title:
	 	  

 
			
		
	 By:
	 	  

 
			
	 Name:
	 	  

 
			
	 Title:
	 	  

  
 46EX-4.2

 Exhibit 4.2 

LUCIRA HEALTH, INC. 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT 

THIS AMENDED AND RESTATED INVESTOR RIGHTS
AGREEMENT (this “Agreement”), is made as of the 7th day of August, 2020, by and among Lucira Health, Inc., a Delaware corporation (the
“Company”), each of the investors listed on SCHEDULE A hereto, each of which is referred to in this Agreement as an “Investor”, and any Additional Purchaser (as defined in the
Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.9 hereof. 

RECITALS 

WHEREAS, certain of the Investors (the “Existing Investors”) hold shares of the Company’s Series A
Preferred Stock, Series B Preferred Stock and/or shares of Common Stock issued upon conversion thereof and possess registration rights, information rights, rights of first offer, and other rights pursuant to that certain Amended and Restated
Investor Rights Agreement dated as of March 11, 2019, by and among the Company and such Existing Investors (the “Prior Agreement”); and 

WHEREAS, the Existing Investors are holders of at least a majority of the Registrable Securities of the Company (as defined in the
Prior Agreement) which majority includes the Major Investors (as defined in the Prior Agreement) holding a majority of the Registrable Securities held by all Major Investors (the “Requisite Majority”), and desire to amend and
restate the Prior Agreement in its entirety and to accept the rights created pursuant to this Agreement in lieu of the rights granted to them under the Prior Agreement; and 

WHEREAS, certain of the Investors are parties to that certain Series C Preferred Stock Purchase Agreement of even date herewith by and
among the Company and such Investors (the “Purchase Agreement”), under which certain of the Company’s and such Investors’ obligations are conditioned upon the execution and delivery of this Agreement by such
Investors, Existing Investors holding at least the Requisite Majority, and the Company; 
 NOW,
THEREFORE, the parties hereby agree as follows: 
 1.
DEFINITIONS. For purposes of this Agreement: 
 1.1 “Affiliate” means,
with respect to any specified Person, any other Person who, directly or indirectly, controls, is controlled by, or is under common control with such Person, including without limitation any general partner, managing member, officer or director of
such Person or any venture capital fund now or hereafter existing that is controlled by one or more general partners or managing members of, or shares the same management company with, such Person. 

1.2 “Board of Directors” means the Company’s Board of Directors. 

1.3 “Common Stock” means shares of the Company’s common stock, par value $0.001 per share. 

1.4 “Competitor” means a Person engaged, directly or indirectly (including through any partnership,
limited liability company, corporation, joint venture or similar arrangement (whether now existing or formed hereafter)), in nucleic acid testing, but shall not include (a) Eclipse Ventures Fund I, L.P. or its Affiliates (collectively,
“EVFI”), (b) Eclipse Fund III, L.P. or its Affiliates (collectively, “EF III”), (c) Seraph Group LLC or its Affiliates (collectively, “Seraph”), (d) EPQ LLC, LFLU PS or its
Affiliates 

 
(collectively, “EPQ LFLU”), EPQ LLC, LCOVD PS or its Affiliates (collectively, “EPQ LCOVD”), (e) Phoenix Venture Partners III LP or its Affiliates
(collectively, “PVP”), or (f) any financial investment firm or collective investment vehicle that, together with its Affiliates, holds less than ten percent (10%) of the outstanding equity of any Competitor and does not,
nor do any of its Affiliates, have a right to designate any members of the board of directors of any Competitor. 
 1.5
“Damages” means any loss, damage, claim or liability (joint or several) to which a party hereto may become subject under the Securities Act, the Exchange Act, or other federal or state law, insofar as such loss, damage, claim
or liability (or any action in respect thereof) arises out of or is based upon: (i) any untrue statement or alleged untrue statement of a material fact contained in any registration statement of the Company, including any preliminary prospectus
or final prospectus contained therein or any amendments or supplements thereto; (ii) an omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make the statements therein not misleading; or
(iii) any violation or alleged violation by the indemnifying party (or any of its agents or Affiliates) of the Securities Act, the Exchange Act, any state securities law, or any rule or regulation promulgated under the Securities
Act, the Exchange Act, or any state securities law. 
 1.6 “Derivative Securities” means any securities or
rights convertible into, or exercisable or exchangeable for (in each case, directly or indirectly), Common Stock, including options and warrants. 

1.7 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder. 
 1.8 “Excluded Registration” means (i) a registration relating to the sale of
securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or similar plan; (ii) a registration relating to an SEC Rule 145 transaction; (iii) a registration on any form that does not include
substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities; or (iv) a registration in which the only Common Stock being registered is Common Stock issuable
upon conversion of debt securities that are also being registered. 
 1.9 “FOIA Party” means a Person that,
in the determination of the Board of Directors, may be subject to, and thereby required to disclose non-public information furnished by or relating to the Company under, the Freedom of Information Act,
5 U.S.C. 552 (“FOIA”), any state public records access law, any state or other jurisdiction’s laws similar in intent or effect to FOIA, or any other similar statutory or regulatory requirement. 

1.10 “Form S-1” means such form under the Securities Act
as in effect on the date hereof or any successor registration form under the Securities Act subsequently adopted by the SEC. 
 1.11
“Form S-3” means such form under the Securities Act as in effect on the date hereof or any registration form under the Securities Act subsequently adopted by the SEC that
permits incorporation of substantial information by reference to other documents filed by the Company with the SEC. 
 1.12
“GAAP” means generally accepted accounting principles in the United States. 
 1.13
“Holder” means any holder of Registrable Securities who is a party to this Agreement. 

  
 2 

 1.14 “Immediate Family Member” means a child, stepchild,
grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law,
father-in-law, son-in-law, daughter-in-law, brother-in-law, or
sister-in-law, including, adoptive relationships, of a natural person referred to herein. 

1.15 “Initiating Holders” means, collectively, Holders who properly initiate a registration request under this
Agreement. 
 1.16 “IPO” means the Company’s first underwritten public offering of its Common Stock
under the Securities Act. 
 1.17 “Major Investor” means any Investor that, individually or together with
such Investor’s Affiliates, holds at least (i) 2,000,000 shares of Series A Preferred Stock and/or Series B Preferred Stock (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected
after the date hereof); or (ii) 8,000,000 shares of Series C Preferred Stock (as adjusted for any stock split, stock dividend, combination, or other recapitalization or reclassification effected after the date hereof). Notwithstanding the foregoing,
Y Combinator Continuity Fund I, L.P. and YCVC Fund I, L.P. shall each be considered a Major Investor for the purposes of the right of first offer set forth in Section 4 hereof. 

1.18 “New Securities” means, collectively, equity securities of the Company, whether or not currently
authorized, as well as rights, options, or warrants to purchase such equity securities, or securities of any type whatsoever that are, or may become, convertible or exchangeable into or exercisable for such equity securities. 

1.19 “Person” means any individual, corporation, partnership, trust, limited liability company, association or
other entity. 
 1.20 “Preferred Directors” means any director of the Company that the holders
of record of any series of Preferred Stock are entitled to elect pursuant to the Restated Certificate. 
 1.21 “Preferred
Stock” means, collectively, shares of the Company’s Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock. 

1.22 “Registrable Securities” means (i) the Common Stock issuable or issued upon conversion of the
Preferred Stock, (ii) any Common Stock currently held or subsequently acquired by the Investors or any Common Stock issued or issuable (directly or indirectly) upon conversion and/or exercise of any other securities of the
Company, and (iii) any Common Stock issued as (or issuable upon the conversion or exercise of any warrant, right, or other security that is issued as) a dividend or other distribution with respect to, or in exchange for or in replacement of,
the shares referenced in clauses (i) and (ii) above; excluding in all cases, however, any Registrable Securities sold by a Person in a transaction in which the applicable rights under this Agreement are not
assigned pursuant to Subsection 6.1, and excluding for purposes of Section 2 any shares for which registration rights have terminated pursuant to Subsection 2.13 of this Agreement. 

1.23 “Registrable Securities then outstanding” means the number of shares determined by adding the number of
shares of outstanding Common Stock that are Registrable Securities and the number of shares of Common Stock issuable (directly or indirectly) pursuant to then exercisable and/or convertible securities that are Registrable Securities. 

1.24 “Restated Certificate” means the Company’s Fourth Amended and Restated Certificate of Incorporation,
as in effect as of the date hereof. 

  
 3 

 1.25 “Restricted Securities” means the securities of the
Company required to be notated with the legend set forth in Subsection 2.12(b) hereof. 
 1.26 “SEC”
means the Securities and Exchange Commission. 
 1.27 “SEC Rule 144” means Rule 144 promulgated by the SEC
under the Securities Act. 
 1.28 “SEC Rule 145” means Rule 145 promulgated by the SEC under the Securities
Act. 
 1.29 “Securities Act” means the Securities Act of 1933, as amended, and the rules and regulations
promulgated thereunder. 
 1.30 “Selling Expenses” means all underwriting discounts, selling commissions, and
stock transfer taxes applicable to the sale of Registrable Securities, and fees and disbursements of counsel for any Holder, except for the fees and disbursements of the Selling Holder Counsel borne and paid by the Company as provided in
Subsection 2.6. 
 1.31 “Series A Preferred Stock” means shares of the Company’s Series A
Preferred Stock, par value $0.001 per share. 
 1.32 “Series B Preferred Stock” means shares of the
Company’s Series B Preferred Stock, par value $0.001 per share. 
 1.33 “Series C Preferred Stock”
means shares of the Company’s Series C Preferred Stock, par value $0.001 per share. 
 2. REGISTRATION
RIGHTS. The Company covenants and agrees as follows: 
 2.1 Demand Registration. 

(a) Form S-1 Demand. If at any time after the earlier of (i) five (5) years after
the date of this Agreement or (ii) one hundred eighty (180) days after the effective date of the registration statement for the IPO, the Company receives a request from Holders of at least forty percent (40%) of the Registrable Securities
then outstanding that the Company file a Form S-1 registration statement with respect to at least thirty percent (30%) of the Registrable Securities then outstanding (or a lesser percent if the
anticipated aggregate offering price, net of Selling Expenses, would exceed $10 million), then the Company shall (x) within ten (10) days after the date such request is given, give notice thereof (the “Demand
Notice”) to all Holders other than the Initiating Holders; and (y) as soon as practicable, and in any event within sixty (60) days after the date such request is given by the Initiating Holders, file a Form S-1 registration statement under the Securities Act covering all Registrable Securities that the Initiating Holders requested to be registered and any additional Registrable Securities requested to be
included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty (20) days of the date the Demand Notice is given, and in each case, subject to the limitations of Subsections
2.1(c) and 2.3. 
 (b) Form S-3 Demand. If at any time when it is eligible
to use a Form S-3 registration statement, the Company receives a request from Holders of at least twenty percent (20%) of the Registrable Securities then outstanding that the Company file a Form S-3 registration statement with respect to outstanding Registrable Securities of such Holders having an anticipated aggregate offering price, 

  
 4 

 
net of Selling Expenses, of at least $2 million, then the Company shall (i) within ten (10) days after the date such request is given, give a Demand Notice to all Holders other
than the Initiating Holders; and (ii) as soon as practicable, and in any event within thirty (30) days after the date such request is given by the Initiating Holders, file a Form S-3 registration
statement under the Securities Act covering all Registrable Securities requested to be included in such registration by any other Holders, as specified by notice given by each such Holder to the Company within twenty (20) days of the date the
Demand Notice is given, and in each case, subject to the limitations of Subsections 2.1(c) and 2.3. 
 (c)
Notwithstanding the foregoing obligations, if the Company furnishes to Holders requesting a registration pursuant to this Subsection 2.1 a certificate signed by the Company’s chief executive officer stating that in the good faith
judgment of the Board of Directors it would be materially detrimental to the Company and its stockholders for such registration statement to either become effective or remain effective for as long as such registration statement otherwise would be
required to remain effective, because such action would (i) materially interfere with a significant acquisition, corporate reorganization, or other similar transaction involving the Company; (ii) require premature disclosure of material
information that the Company has a bona fide business purpose for preserving as confidential; or (iii) render the Company unable to comply with requirements under the Securities Act or Exchange Act, then the Company shall have the right to
defer taking action with respect to such filing, and any time periods with respect to filing or effectiveness thereof shall be tolled correspondingly, for a period of not more than one hundred twenty (120) days after the request of the
Initiating Holders is given; provided, however, that the Company may not invoke this right more than once in any twelve (12) month period ; and provided further that the Company shall not register any securities for
its own account or that of any other stockholder during such one hundred twenty (120) day period pursuant to a registration relating to the sale of securities to employees of the Company or a subsidiary pursuant to a stock option, stock
purchase, or similar plan; a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities; or a registration in
which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered. 

(d) The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to Subsection
2.1(a)(i) during the period that is sixty (60) days before the Company’s good faith estimate of the date of filing of, and ending on a date that is one hundred eighty (180) days after the effective date of, a Company-initiated
registration, provided that the Company is actively employing in good faith commercially reasonable efforts to cause such registration statement to become effective; (ii) after the Company has effected one registration pursuant to
Subsection 2.1(a); or (iii) if the Initiating Holders propose to dispose of shares of Registrable Securities that may be immediately registered on Form S-3 pursuant to a request made pursuant to
Subsection 2.1(b). The Company shall not be obligated to effect, or to take any action to effect, any registration pursuant to Subsection 2.1(b) (i) during the period that is thirty (30) days before the Company’s good
faith estimate of the date of filing of, and ending on a date that is ninety (90) days after the effective date of, a Company-initiated registration, provided that the Company is actively employing in good faith commercially reasonable
efforts to cause such registration statement to become effective; or (ii) if the Company has effected a registration pursuant to Subsection 2.1(b) within the twelve (12) month period immediately preceding the date of such request. A
registration shall not be counted as “effected” for purposes of this Subsection 2.1(d) (i) until such time as the applicable registration statement has been declared effective by the SEC, unless the Initiating Holders withdraw
their request for such registration, elect not to pay the registration expenses therefor, and forfeit their right to one demand registration statement pursuant to Subsection 2.6, in which case such withdrawn registration statement shall be
counted as “effected” for purposes of this Subsection 2.1(d) or (ii) if, as a result of an exercise of the underwriter’s cutback provisions, fewer than fifty percent (50%) of the total number of Registrable Securities that
Holders have requested to be included in such registration statement are actually included. 

  
 5 

 2.2 Company Registration. If the Company proposes to register (including, for
this purpose, a registration effected by the Company for stockholders other than the Holders) any of its Common Stock under the Securities Act in connection with the public offering of such securities solely for cash (other than in an Excluded
Registration), the Company shall, at such time, promptly give each Holder notice of such registration. Upon the request of each Holder given within twenty (20) days after such notice is given by the Company, the Company shall, subject to the
provisions of Subsection 2.3, cause to be registered all of the Registrable Securities that each such Holder has requested to be included in such registration. The Company shall have the right to terminate or withdraw any registration
initiated by it under this Subsection 2.2 before the effective date of such registration, whether or not any Holder has elected to include Registrable Securities in such registration. The expenses (other than Selling Expenses) of such
withdrawn registration shall be borne by the Company in accordance with Subsection 2.6. 
 2.3 Underwriting Requirements. 

(a) If, pursuant to Subsection 2.1, the Initiating Holders intend to distribute the Registrable Securities covered by
their request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to Subsection 2.1, and the Company shall include such information in the Demand Notice. The underwriter(s) will be selected
by the Company and shall be reasonably acceptable to a majority in interest of the Initiating Holders. In such event, the right of any Holder to include such Holder’s Registrable Securities in such registration shall be conditioned upon such
Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders proposing to distribute their securities through such underwriting shall
(together with the Company as provided in Subsection 2.4(e)) enter into an underwriting agreement in customary form with the underwriter(s) selected for such underwriting. Notwithstanding any other provision of this Subsection 2.3, if
the managing underwriter(s) advise(s) the Initiating Holders in writing that marketing factors require a limitation on the number of shares to be underwritten, then the Initiating Holders shall so advise all Holders of Registrable Securities that
otherwise would be underwritten pursuant hereto, and the number of Registrable Securities that may be included in the underwriting shall be allocated among such Holders of Registrable Securities, including the Initiating Holders, in proportion (as
nearly as practicable) to the number of Registrable Securities owned by each Holder and submitted for inclusion in such offering or in such other proportion as shall mutually be agreed to by all such selling Holders; provided, however,
that the number of Registrable Securities held by the Holders to be included in such underwriting shall not be reduced unless all other securities are first entirely excluded from the underwriting. To facilitate the allocation of shares in
accordance with the above provisions, the Company or the underwriters may round the number of shares allocated to any Holder to the nearest one hundred (100) shares. 

(b) In connection with any offering involving an underwriting of shares of the Company’s capital stock pursuant to Subsection
2.2, the Company shall not be required to include any of the Holders’ Registrable Securities in such underwriting unless the Holders accept the terms of the underwriting as agreed upon between the Company and its underwriters, and then only
in such quantity as the underwriters in their sole discretion determine will not jeopardize the success of the offering by the Company. If the total number of securities, including Registrable Securities, requested by stockholders to be included in
such offering exceeds the number of securities to be sold (other than by the Company) that the underwriters in their reasonable discretion determine is compatible with the success of the offering, then the Company shall be required to include in the
offering only that number of such securities, including Registrable Securities, which the underwriters and the Company in their sole discretion determine will not jeopardize the success of the offering. If the underwriters determine that less than
all of the Registrable Securities requested to be registered can be included in such offering, then the Registrable Securities that are included in such offering shall be allocated among the selling Holders in proportion (as nearly as practicable
to) the number of Registrable Securities owned by each selling Holder or in such other 

  
 6 

 
proportions as shall mutually be agreed to by all such selling Holders. To facilitate the allocation of shares in accordance with the above provisions, the Company or the underwriters may round
the number of shares allocated to any Holder to the nearest one hundred (100) shares. Notwithstanding the foregoing, in no event shall (i) the number of Registrable Securities included in the offering be reduced unless all other securities
(other than securities to be sold by the Company) are first entirely excluded from the offering, or (ii) the number of Registrable Securities included in the offering be reduced below twenty percent (20%) of the total number of securities
included in such offering, unless such offering is the IPO, in which case the selling Holders may be excluded further if the underwriters make the determination described above and no other stockholder’s securities are included in such
offering. For purposes of the provision in this Subsection 2.3(b) concerning apportionment, for any selling Holder that is a partnership, limited liability company, or corporation, the partners, members, retired partners, retired members,
stockholders, and Affiliates of such Holder, or the estates and Immediate Family Members of any such partners, retired partners, members, and retired members and any trusts for the benefit of any of the foregoing Persons, shall be deemed to be a
single “selling Holder,” and any pro rata reduction with respect to such “selling Holder” shall be based upon the aggregate number of Registrable Securities owned by all Persons included in such “selling Holder,” as
defined in this sentence. 
 2.4 Obligations of the Company. Whenever required under this Section 2
to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 
 (a) prepare
and file with the SEC a registration statement with respect to such Registrable Securities and use its commercially reasonable efforts to cause such registration statement to become effective and, upon the request of the Holders of a majority of the
Registrable Securities registered thereunder, keep such registration statement effective for a period of up to one hundred twenty (120) days or, if earlier, until the distribution contemplated in the registration statement has been completed;
provided, however, that (i) such one hundred twenty (120) day period shall be extended for a period of time equal to the period the Holder refrains, at the request of an underwriter of Common Stock (or other securities) of
the Company, from selling any securities included in such registration; 
 (b) prepare and file with the SEC such amendments and
supplements to such registration statement, and the prospectus used in connection with such registration statement, as may be necessary to comply with the Securities Act in order to enable the disposition of all securities covered by such
registration statement; 
 (c) furnish to the selling Holders such numbers of copies of a prospectus, including a preliminary
prospectus, as required by the Securities Act, and such other documents as the Holders may reasonably request in order to facilitate their disposition of their Registrable Securities; 

(d) use its commercially reasonable efforts to register and qualify the securities covered by such registration statement under such
other securities or blue-sky laws of such jurisdictions as shall be reasonably requested by the selling Holders; provided that the Company shall not be required to qualify to do business or to file a
general consent to service of process in any such states or jurisdictions, unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act; 

(e) immediately notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus
relating thereto is required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or
omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances then existing, and at the request of the Holders promptly prepare and furnish to the Holders

  
 7 

 
a reasonable number of copies of a supplement to, or an amendment of, such prospectus as may be necessary so that, as thereafter delivered to the purchasers of such securities, such prospectus
shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of the circumstances under which they were made; 

(f) in the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual
and customary form, with the underwriter(s) of such offering; 
 (g) cause senior representatives of the Company to participate in
any “road show” or “road shows” reasonably requested by any underwriter of an underwritten or “best efforts” offering of any Registrable Securities; 

(h) use its commercially reasonable efforts to furnish, on the date that such Registrable Securities are delivered to the underwriters
for sale, if such securities are being sold through underwriters, (i) an opinion, dated as of such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to
underwriters in an underwritten public offering, addressed to the underwriters, if any, and (ii) a letter dated as of such date, from the independent public accountants of the Company, in form and substance as is customarily given by
independent public accountants to underwriters in an underwritten public offering addressed to the underwriters; 
 (i) cooperate
with the sellers and the managing underwriter to facilitate the timely preparation and delivery of certificates (which shall not bear any restrictive legends unless required under applicable law) representing securities sold under any registration
statement, and enable such securities to be in such denominations and registered in such names as the managing underwriter or such sellers may request and keep available and make available to the Company’s transfer agent prior to the
effectiveness of such registration statement a supply of such certificates; 
 (j) use its commercially reasonable efforts to cause
all such Registrable Securities covered by such registration statement to be listed on a national securities exchange or trading system and each securities exchange and trading system (if any) on which similar securities issued by the Company are
then listed; 
 (k) provide a transfer agent and registrar for all Registrable Securities registered pursuant to this Agreement and
provide a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration; 

(l) promptly make available for inspection by the selling Holders, any managing underwriter(s) participating in any disposition
pursuant to such registration statement, and any attorney or accountant or other agent retained by any such underwriter or selected by the selling Holders, all financial and other records, pertinent corporate documents, and properties of the
Company, and cause the Company’s officers, directors, employees, and independent accountants to supply all information reasonably requested by any such seller, underwriter, attorney, accountant, or agent, in each case, as necessary or advisable
to verify the accuracy of the information in such registration statement and to conduct appropriate due diligence in connection therewith; 

(m) notify each selling Holder, promptly after the Company receives notice thereof, of the time when such registration statement has
been declared effective or a supplement to any prospectus forming a part of such registration statement has been filed; and 

  
 8 

 (n) after such registration statement becomes effective, notify each selling Holder
of any request by the SEC that the Company amend or supplement such registration statement or prospectus. 
 In addition, the Company shall
ensure that, at all times after any registration statement covering a public offering of securities of the Company under the Securities Act shall have become effective, its insider trading policy shall provide that the Company’s directors may
implement a trading program under Rule 10b5-1 of the Exchange Act. 
 2.5 Furnish
Information. It shall be a condition precedent to the obligations of the Company to take any action pursuant to this Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall
furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of such securities as is reasonably required to effect the registration of such Holder’s Registrable
Securities. 
 2.6 Expenses of Registration. All expenses (other than Selling Expenses) incurred in connection with
registrations, filings, or qualifications pursuant to Section 2, including all registration, filing, and qualification fees; printers’ and accounting fees; fees and disbursements of counsel for the Company; and the
reasonable fees and disbursements, not to exceed $35,000, of one counsel for the selling Holders selected by a majority-in-interest of the selling Holders
(“Selling Holder Counsel”), shall be borne and paid by the Company; provided, however, that the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to
Subsection 2.1 if the registration request is subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered (in which case all selling Holders shall bear such expenses pro rata based upon
the number of Registrable Securities that were to be included in the withdrawn registration), unless the Holders of a majority of the Registrable Securities agree to forfeit their right to one registration pursuant to Subsections 2.1(a) or
2.1(b), as the case may be. All Selling Expenses relating to Registrable Securities registered pursuant to this Section 2 shall be borne and paid by the Holders pro rata on the basis of the number of Registrable
Securities registered on their behalf. 
 2.7 Delay of Registration. No Holder shall have any right to obtain or seek an
injunction restraining or otherwise delaying any registration pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

2.8 Indemnification. If any Registrable Securities are included in a registration statement under this
Section 2: 
 (a) To the extent permitted by law, the Company will indemnify and hold harmless each
selling Holder, and the partners, members, officers, directors, and stockholders of each such Holder; legal counsel and accountants for each such Holder; any underwriter (as defined in the Securities Act) for each such Holder; and each Person, if
any, who controls such Holder or underwriter within the meaning of the Securities Act or the Exchange Act, against any Damages, and the Company will pay to each such Holder, underwriter, controlling Person, or other aforementioned Person any legal
or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which Damages may result, as such expenses are incurred; provided, however, that the indemnity agreement contained
in this Subsection 2.8(a) shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the consent of the Company, which consent shall not be unreasonably withheld, nor shall the Company
be liable for any Damages to the extent that they arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of any such Holder, underwriter, controlling Person, or
other aforementioned Person expressly for use in connection with such registration. 

  
 9 

 (b) To the extent permitted by law, each selling Holder, severally and not jointly,
will indemnify and hold harmless the Company, and each of its directors, each of its officers who has signed the registration statement, each Person (if any), who controls the Company within the meaning of the Securities Act, legal counsel and
accountants for the Company, any underwriter (as defined in the Securities Act), any other Holder selling securities in such registration statement, and any controlling Person of any such underwriter or other Holder, against any Damages, in each
case only to the extent that such Damages arise out of or are based upon actions or omissions made in reliance upon and in conformity with written information furnished by or on behalf of such selling Holder expressly for use in connection with such
registration; and each such selling Holder will pay to the Company and each other aforementioned Person any legal or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which Damages
may result, as such expenses are incurred; provided, however, that the indemnity agreement contained in this Subsection 2.8(b) shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is
effected without the consent of the Holder, which consent shall not be unreasonably withheld; and provided further that in no event shall the aggregate amounts payable by any Holder by way of indemnity or contribution under
Subsections 2.8(b) and 2.8(d) exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of fraud or willful misconduct by such Holder. 

(c) Promptly after receipt by an indemnified party under this Subsection 2.8 of notice of the commencement of any action
(including any governmental action) for which a party may be entitled to indemnification hereunder, such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Subsection 2.8, give the
indemnifying party notice of the commencement thereof. The indemnifying party shall have the right to participate in such action and, to the extent the indemnifying party so desires, participate jointly with any other indemnifying party to which
notice has been given, and to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties that may be represented without
conflict by one counsel) shall have the right to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified party by the counsel retained by the indemnifying party would be
inappropriate due to actual or potential differing interests between such indemnified party and any other party represented by such counsel in such action. The failure to give notice to the indemnifying party within a reasonable time of the
commencement of any such action shall relieve such indemnifying party of any liability to the indemnified party under this Subsection 2.8, to the extent that such failure materially prejudices the indemnifying party’s ability to defend
such action. The failure to give notice to the indemnifying party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Subsection 2.8. 

(d) To provide for just and equitable contribution to joint liability under the Securities Act in any case in which either:
(i) any party otherwise entitled to indemnification hereunder makes a claim for indemnification pursuant to this Subsection 2.8 but it is judicially determined (by the entry of a final judgment or decree by a court of competent
jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may not be enforced in such case, notwithstanding the fact that this Subsection 2.8 provides for indemnification in such
case, or (ii) contribution under the Securities Act may be required on the part of any party hereto for which indemnification is provided under this Subsection 2.8, then, and in each such case, such parties will contribute to the
aggregate losses, claims, damages, liabilities, or expenses to which they may be subject (after contribution from others) in such proportion as is appropriate to reflect the relative fault of each of the indemnifying party and the indemnified party
in connection with the statements, omissions, or other actions that resulted in such loss, claim, damage, liability, or expense, as well as to reflect any other relevant equitable considerations. The relative fault of the indemnifying party and of
the indemnified party shall be determined by reference to, among other things, whether the untrue or allegedly untrue statement of a material fact, or the omission or alleged omission of a material fact, relates to information supplied by the

  
 10 

 
indemnifying party or by the indemnified party and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission;
provided, however, that, in any such case (x) no Holder will be required to contribute any amount in excess of the public offering price of all such Registrable Securities offered and sold by such Holder pursuant to such
registration statement, and (y) no Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) will be entitled to contribution from any Person who was not guilty of such fraudulent
misrepresentation; and provided further that in no event shall a Holder’s liability pursuant to this Subsection 2.8(d), when combined with the amounts paid or payable by such Holder pursuant to Subsection 2.8(b),
exceed the proceeds from the offering received by such Holder (net of any Selling Expenses paid by such Holder), except in the case of willful misconduct or fraud by such Holder. 

(e) Notwithstanding the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting
agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 

(f) Unless otherwise superseded by an underwriting agreement entered into in connection with the underwritten public offering, the
obligations of the Company and Holders under this Subsection 2.8 shall survive the completion of any offering of Registrable Securities in a registration under this Section 2, and otherwise shall survive the
termination of this Agreement. 
 2.9 Reports Under Exchange Act. With a view to making available to the Holders the benefits
of SEC Rule 144 and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form S-3,
the Company shall: 
 (a) make and keep available adequate current public information, as those terms are understood and defined in
SEC Rule 144, at all times after the effective date of the registration statement filed by the Company for the IPO; 
 (b) use
commercially reasonable efforts to file with the SEC in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act (at any time after the Company has become subject to such reporting
requirements); and 
 (c) furnish to any Holder, so long as the Holder owns any Registrable Securities, forthwith upon request
(i) to the extent accurate, a written statement by the Company that it has complied with the reporting requirements of SEC Rule 144 (at any time after ninety (90) days after the effective date of the registration statement filed by the
Company for the IPO), the Securities Act, and the Exchange Act (at any time after the Company has become subject to such reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after the Company so qualifies); (ii) a copy of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company; and (iii) such other
information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC that permits the selling of any such securities without registration (at any time after the Company has become subject to the reporting
requirements under the Exchange Act) or pursuant to Form S-3 (at any time after the Company so qualifies to use such form). 

2.10 Limitations on Subsequent Registration Rights. From and after the date of this Agreement, the Company shall not, without
the prior written consent of the Holders of a majority of the Registrable Securities then outstanding, enter into any agreement with any holder or prospective holder of any securities of the Company that (i) would provide to such holder the
right to include securities in any 

  
 11 

 
registration on other than either a pro rata basis with respect to the Registrable Securities or on a subordinate basis after all Holders have had the opportunity to include in the registration
and offering all shares of Registrable Securities that they wish to so include or (ii) allow such holder or prospective holder to initiate a demand for registration of any securities held by such holder or prospective holder; provided
that this limitation shall not apply to any additional Investor who becomes a party to this Agreement in accordance with Subsection 6.9. 

2.11 “Market Stand-off” Agreement. Each Holder
hereby agrees that it will not, without the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus relating to the registration by the Company of shares of its Common Stock or any other
equity securities under the Securities Act on a registration statement on Form S-1, and ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred
eighty (180) days), (i) lend; offer; pledge; sell; contract to sell; sell any option or contract to purchase; purchase any option or contract to sell; grant any option, right, or warrant to purchase; or otherwise transfer or dispose of,
directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable (directly or indirectly) for Common Stock (whether such shares or any such securities are then owned by the Holder or are thereafter
acquired) or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership of such securities, whether any such transaction described in clause (i) or (ii) above
is to be settled by delivery of Common Stock or other securities, in cash, or otherwise. The foregoing provisions of this Subsection 2.11 shall apply only to the IPO and shall not apply to the sale of any shares to an underwriter
pursuant to an underwriting agreement, or the transfer of any shares to any trust for the direct or indirect benefit of the Holder or the immediate family of the Holder, provided that the trustee of the trust agrees to be bound in writing by
the restrictions set forth herein, and provided further that any such transfer shall not involve a disposition for value, and shall be applicable to the Holders only if all officers and directors are subject to the same restrictions
and the Company uses commercially reasonable efforts to obtain a similar agreement from all stockholders individually owning more than one percent (1%) of the Company’s outstanding Common Stock (after giving effect to conversion into Common
Stock of all outstanding Preferred Stock). The underwriters in connection with such registration are intended third-party beneficiaries of this Subsection 2.11 and shall have the right, power and
authority to enforce the provisions hereof as though they were a party hereto. Each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in connection with such registration that are consistent with
this Subsection 2.11 or that are necessary to give further effect thereto. Any discretionary waiver or termination of the restrictions of any or all of such agreements by the Company or the underwriters shall apply pro rata to all Holders
subject to such agreements, based on the number of shares subject to such agreements. 
 2.12 Restrictions on Transfer. 

(a) The Preferred Stock and the Registrable Securities shall not be sold, pledged, or otherwise transferred, and the Company shall not
recognize and shall issue stop-transfer instructions to its transfer agent with respect to any such sale, pledge, or transfer, except upon the conditions specified in this Agreement, which conditions are intended to ensure compliance with the
provisions of the Securities Act. A transferring Holder will cause any proposed purchaser, pledgee, or transferee of the Preferred Stock and the Registrable Securities held by such Holder to agree to take and hold such securities subject to the
provisions and upon the conditions specified in this Agreement. 
 (b) Each certificate, instrument, or book entry representing
(i) the Preferred Stock, (ii) the Registrable Securities, and (iii) any other securities issued in respect of the securities referenced in clauses (i) and (ii), upon any stock split, stock dividend, recapitalization, merger,
consolidation, or similar event, shall (unless otherwise permitted by the provisions of Subsection 2.12(c)) be notated with a legend substantially in the following form: 

  
 12 

 THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933. SUCH SHARES MAY NOT BE SOLD, PLEDGED, OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR A VALID EXEMPTION FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF SAID ACT. 

THE SECURITIES REPRESENTED HEREBY MAY BE TRANSFERRED ONLY IN ACCORDANCE WITH THE TERMS OF AN AGREEMENT BETWEEN THE COMPANY AND THE STOCKHOLDER,
A COPY OF WHICH IS ON FILE WITH THE SECRETARY OF THE COMPANY. 
 The Holders consent to the Company making a notation in its records and
giving instructions to any transfer agent of the Restricted Securities in order to implement the restrictions on transfer set forth in this Subsection 2.12. 

(c) The holder of such Restricted Securities, by acceptance of ownership thereof, agrees to comply in all respects with the provisions
of this Section 2. Before any proposed sale, pledge, or transfer of any Restricted Securities, unless there is in effect a registration statement under the Securities Act covering the proposed transaction, the Holder
thereof shall give notice to the Company of such Holder’s intention to effect such sale, pledge, or transfer. Each such notice shall describe the manner and circumstances of the proposed sale, pledge, or transfer in sufficient detail and, if
reasonably requested by the Company, shall be accompanied at such Holder’s expense by either (i) a written opinion of legal counsel who shall, and whose legal opinion shall, be reasonably satisfactory to the Company, addressed to the
Company, to the effect that the proposed transaction may be effected without registration under the Securities Act; (ii) a “no action” letter from the SEC to the effect that the proposed sale, pledge, or transfer of such Restricted
Securities without registration will not result in a recommendation by the staff of the SEC that action be taken with respect thereto; or (iii) any other evidence reasonably satisfactory to counsel to the Company to the effect that the proposed
sale, pledge, or transfer of the Restricted Securities may be effected without registration under the Securities Act, whereupon the Holder of such Restricted Securities shall be entitled to sell, pledge, or transfer such Restricted Securities in
accordance with the terms of the notice given by the Holder to the Company. The Company will not require such a legal opinion or “no action” letter (x) in any transaction in compliance with SEC Rule 144; or (y) in any transaction
in which such Holder distributes Restricted Securities to an Affiliate of such Holder for no consideration; provided that each transferee agrees in writing to be subject to the terms of this Subsection 2.12. Each certificate,
instrument, or book entry representing the Restricted Securities transferred as above provided shall be notated with, except if such transfer is made pursuant to SEC Rule 144, the appropriate restrictive legend set forth in Subsection
2.12(b), except that such certificate instrument, or book entry shall not be notated with such restrictive legend if, in the opinion of counsel for such Holder and the Company, such legend is not required in order to establish compliance with
any provisions of the Securities Act. 
 2.13 Termination of Registration Rights. The right of any Holder to request
registration or inclusion of Registrable Securities in any registration pursuant to Subsections 2.1 or 2.2 shall terminate upon the earliest to occur of: 

(a) upon a Deemed Liquidation Event, as such term is defined and applied in the Restated Certificate; 

(b) such time after consummation of the IPO as Rule 144 or another similar exemption under the Securities Act is available for the
sale of all of such Holder’s shares without limitation during a three-month period without registration; and 

  
 13 

 (c) the third anniversary of the Qualified IPO (as defined in the Restated
Certificate). 
 3. INFORMATION AND OBSERVER RIGHTS. 

3.1 Delivery of Financial Statements. The Company shall deliver to each Major Investor, provided that the Board of
Directors has not reasonably determined that such Major Investor is a Competitor of the Company: 
 (a) as soon as practicable, but
in any event within one hundred twenty (120) days after the end of each fiscal year of the Company (i) an unaudited balance sheet as of the end of such year, (ii) unaudited statements of income and of cash flows for such year, and
(iii) an unaudited statement of stockholders’ equity as of the end of such year; 
 (b) as soon as practicable, but in any
event within forty-five (45) days after the end of each of the first three (3) quarters of each fiscal year of the Company, unaudited statements of income and cash flows for such fiscal quarter, and
an unaudited balance sheet and a statement of stockholders’ equity as of the end of such fiscal quarter, all prepared in accordance with GAAP (except that such financial statements may (i) be subject to normal year-end audit adjustments; and (ii) not contain all notes thereto that may be required in accordance with GAAP); 

(c) as soon as practicable, but in any event within thirty (30) days of the end of each month, an unaudited income statement and
statement of cash flows for such month, and an unaudited balance sheet and statement of stockholders’ equity as of the end of such month, all prepared in accordance with GAAP (except that such financial statements may (i) be subject to
normal year-end audit adjustments and (ii) not contain all notes thereto that may be required in accordance with GAAP); and 

(d) as soon as practicable, but in any event within thirty (30) days of the end of each fiscal year, a business plan and a budget
for the next fiscal year, prepared on a monthly basis, including balance sheets, income statements, and statements of cash flow for such months and, promptly after prepared, any other budgets or revised budgets prepared by the Company; and 

(e) such other information relating to the financial condition, business, prospects, or corporate affairs of the Company as any Major
Investor may from time to time reasonably request; provided, however, that the Company shall not be obligated under this Subsection 3.1 to provide information (i) that the Company reasonably determines in good faith to be a
trade secret or confidential information (unless covered by an enforceable confidentiality agreement, in a form acceptable to the Company); or (ii) the disclosure of which would adversely affect the attorney-client privilege between the Company
and its counsel. 
 If, for any period, the Company has any subsidiary whose accounts are consolidated with those of the Company, then in
respect of such period the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such consolidated subsidiaries. 

Notwithstanding anything else in this Subsection 3.1 to the contrary, the Company may cease providing the information set forth in this
Subsection 3.1 during the period starting with the date sixty (60) days before the Company’s good-faith estimate of the date of filing of a registration statement if it reasonably concludes it must do so to comply with the SEC rules
applicable to such registration statement and related offering; provided that the Company’s covenants under this Subsection 3.1 shall be reinstated at such time as the Company is no longer actively employing its commercially
reasonable efforts to cause such registration statement to become effective. 

  
 14 

 3.2 Inspection. The Company shall permit each Major Investor (provided
that the Board of Directors has not reasonably determined that such Major Investor is a competitor of the Company), at such Major Investor’s expense, to visit and inspect the Company’s properties; examine its books of account and records;
and discuss the Company’s affairs, finances, and accounts with its officers, during normal business hours of the Company as may be reasonably requested by the Major Investor; provided, however, that the Company shall not be
obligated pursuant to this Subsection 3.2 to provide access to any information that it reasonably and in good faith considers to be a trade secret or confidential information (unless covered by an enforceable confidentiality agreement, in
form acceptable to the Company) or the disclosure of which would adversely affect the attorney-client privilege between the Company and its counsel. 

3.3 Termination of Information. The covenants set forth in Subsection 3.1 and Subsection 3.2 shall terminate and
be of no further force or effect (i) immediately before the consummation of the Qualified IPO, or (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act,
or (iii) upon a Deemed Liquidation Event, as such term is defined and applied in the Restated Certificate, whichever event occurs first. 

3.4 Confidentiality. Each Investor agrees that such Investor will keep confidential and will not disclose, divulge, or use for
any purpose (other than to monitor its investment in the Company) any confidential information obtained from the Company pursuant to the terms of this Agreement (including notice of the Company’s intention to file a registration statement),
unless such confidential information (a) is known or becomes known to the public in general (other than as a result of a breach of this Subsection 3.4 by such Investor), (b) is or has been independently developed or conceived by the
Investor without use of the Company’s confidential information, or (c) is or has been made known or disclosed to the Investor by a third party without a breach of any obligation of confidentiality such third party may have to the Company;
provided, however, that an Investor may disclose confidential information (i) to its attorneys, accountants, consultants, and other professionals to the extent necessary to obtain their services in connection with monitoring its
investment in the Company; (ii) to any prospective purchaser of any Registrable Securities from such Investor, if such prospective purchaser agrees to be bound by the provisions of this Subsection 3.4; (iii) to any existing
Affiliate, partner, member, stockholder, or wholly owned subsidiary of such Investor in the ordinary course of business, provided that such Investor informs such Person that such information is confidential and directs such Person to maintain
the confidentiality of such information; or (iv) as may otherwise be required by law, provided that the Investor promptly notifies the Company of such disclosure and takes reasonable steps to minimize the extent of any such required
disclosure. 
 4. RIGHTS TO FUTURE STOCK ISSUANCES. 

4.1 Right of First Offer. Subject to the terms and conditions of this Subsection 4.1 and applicable securities laws, if
the Company proposes to offer or sell any New Securities, the Company shall first offer such New Securities to each Major Investor. A Major Investor shall be entitled to apportion the right of first offer hereby granted to it in such proportions as
it deems appropriate, among (i) itself and (ii) its Affiliates, as approved by the Company. 
 (a) The Company shall give
notice (the “Offer Notice”) to each Major Investor, stating (i) its bona fide intention to offer such New Securities, (ii) the number of such New Securities to be offered, and (iii) the price and terms, if any,
upon which it proposes to offer such New Securities. 

  
 15 

 (b) By notification to the Company within twenty (20) days after the Offer
Notice is given, each Major Investor may elect to purchase or otherwise acquire, at the price and on the terms specified in the Offer Notice, up to that portion of such New Securities which equals the proportion that the Common Stock then held by
such Major Investor (including all shares of Common Stock then issuable (directly or indirectly) upon conversion and/or exercise, as applicable, of the Preferred Stock and any other Derivative Securities then held by such Major Investor) bears to
the total Common Stock of the Company then outstanding (assuming full conversion and/or exercise, as applicable, of all Preferred Stock and other Derivative Securities). At the expiration of such twenty (20) day period, the Company shall
promptly notify each Major Investor that elects to purchase or acquire all the shares available to it (each, a “Fully Exercising Investor”) of any other Major Investor’s failure to do likewise. During the ten
(10) day period commencing after the Company has given such notice, each Fully Exercising Investor may, by giving notice to the Company, elect to purchase or acquire, in addition to the number of shares specified above, up to that portion of
the New Securities for which Major Investors were entitled to subscribe but that were not subscribed for by the Major Investors which is equal to the proportion that the Common Stock issued and held, or issuable (directly or indirectly) upon
conversion and/or exercise, as applicable, of Preferred Stock and any other Derivative Securities then held, by such Fully Exercising Investor bears to the Common Stock issued and held, or issuable (directly or indirectly) upon conversion and/or
exercise, as applicable, of the Preferred Stock and any other Derivative Securities then held, by all Fully Exercising Investors who wish to purchase such unsubscribed shares. The closing of any sale pursuant to this Subsection 4.1(b)
shall occur within the later of ninety (90) days of the date that the Offer Notice is given and the date of initial sale of New Securities pursuant to Subsection 4.1(c). 

(c) If all New Securities referred to in the Offer Notice are not elected to be purchased or acquired as provided in Subsection
4.1(b), the Company may, during the sixty (60) day period following the expiration of the periods provided in Subsection 4.1(b), offer and sell the remaining unsubscribed portion of such New Securities to any Person or Persons at a
price not less than, and upon terms no more favorable to the offeree than, those specified in the Offer Notice. If the Company does not enter into an agreement for the sale of the New Securities within such period, or if such agreement is not
consummated within thirty (30) days of the execution thereof, the right provided hereunder shall be deemed to be revived and such New Securities shall not be offered unless first reoffered to the Major Investors in accordance with this
Subsection 4.1. 
 (d) The right of first offer in this Subsection 4.1 shall not be applicable to (i) Exempted
Securities (as defined in the Restated Certificate) and (ii) the issuance of shares of Preferred Stock to Additional Purchasers pursuant to Subsection 1.3 of the Purchase Agreement. 

4.2 Termination. The covenants set forth in Subsection 4.1 shall terminate and be of no further force or effect
(i) immediately before the consummation of the Qualified IPO, (ii) when the Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed Liquidation
Event, whichever event occurs first and, as to each Major Investor, in accordance with Subsection 4.1(e). 
 5.
ADDITIONAL COVENANTS. 
 5.1 Insurance. The Company shall use its commercially reasonable
efforts to maintain Directors and Officers liability insurance in an amount and on terms and conditions satisfactory to the Board of Directors, and will use commercially reasonable efforts to cause such insurance policies to be maintained until such
time as the Board of Directors determines that such insurance should be discontinued. 

  
 16 

 5.2 Employee Agreements. The Company will cause (i) each person now or
hereafter employed by it or by any subsidiary (or engaged by the Company or any subsidiary as a consultant/independent contractor) with access to confidential information and/or trade secrets to enter into a nondisclosure and proprietary rights
assignment agreement in the form approved by the Board of Directors. In addition, the Company shall not amend, modify, terminate, waive, or otherwise alter, in whole or in part, any of the above-referenced agreements or any restricted stock
agreement between the Company and any employee, without the approval of the Board of Directors, including a majority of the Preferred Directors. 

5.3 Employee Stock. Unless otherwise approved by the Board of Directors, all future employees and consultants of the Company who
purchase, receive options to purchase, or receive awards of shares of the Company’s capital stock after the date hereof shall be required to execute restricted stock or option agreements, as applicable, providing for (i) vesting of shares
over a four (4) year period, with the first twenty-five percent (25%) of such shares vesting following twelve (12) months of continued employment or service, and the remaining shares vesting in equal monthly installments over the following
thirty-six (36) months, and (ii) a market stand-off provision substantially similar to that in Subsection 2.11. In addition, unless otherwise approved
by the Board of Directors, the Company shall retain a “right of first refusal” on employee transfers until the Company’s IPO and shall have the right to repurchase unvested shares at cost upon termination of employment of a
holder of restricted stock. 
 5.4 Board Matters. The Company shall reimburse the directors for all reasonable out-of-pocket travel expenses incurred in connection with attending meetings of the Board of Directors. If the current Board of Directors has not yet approved the budget for
the current fiscal year as of the Closing, the Company’s management shall present the budget for the current fiscal year to the Board of Directors for approval by the Board of Directors, in the Board of Directors’ first meeting after the
Closing. 
 5.5 Successor Indemnification. If the Company or any of its successors or assignees consolidates with or
merges into any other Person and is not the continuing or surviving corporation or entity of such consolidation or merger, then to the extent necessary, proper provision shall be made so that the successors and assignees of the Company assume the
obligations of the Company with respect to indemnification of members of the Board of Directors as in effect immediately before such transaction, whether such obligations are contained in the Company’s Bylaws, the Restated Certificate, or
elsewhere, as the case may be. This Section 5.5 shall survive any termination of this Agreement. 
 5.6
Indemnification Matters. The Company hereby acknowledges that one (1) or more of the directors nominated to serve on the Board of Directors by the Investors (each a “Fund Director”) may have certain rights
to indemnification, advancement of expenses and/or insurance provided by one or more of the Investors and certain of their affiliates (collectively, the “Fund Indemnitors”). The Company hereby agrees (a) that it is the
indemnitor of first resort (i.e., its obligations to any such Fund Director are primary and any obligation of the Fund Indemnitors to advance expenses or to provide indemnification for the same expenses or liabilities incurred by such Fund
Director are secondary), (b) that it shall be required to advance the full amount of expenses incurred by such Fund Director and shall be liable for the full amount of all expenses, judgments, penalties, fines and amounts paid in settlement by or on
behalf of any such Fund Director to the extent legally permitted and as required by the Restated Certificate or Bylaws of the Company (or any agreement between the Company and such Fund Director), without regard to any rights such Fund Director may
have against the Fund Indemnitors, and, (c) that it irrevocably waives, relinquishes and releases the Fund Indemnitors from any and all claims against the Fund Indemnitors for contribution, subrogation or any other recovery of any kind in
respect thereof. The Company further agrees that no advancement or payment by the Fund Indemnitors on behalf of any such Fund Director with respect to any claim for which such Fund Director has sought indemnification from the Company shall
affect the foregoing and the Fund Indemnitors shall have a right of contribution and/or be subrogated to the extent of such advancement or payment to all of the rights of recovery of such Fund Director against the Company. 

  
 17 

 5.7 Right to Conduct Activities. The Company hereby agrees and acknowledges
that each of EVFI, EF III, Seraph, EPQ LFLU, EPQ LCOVD and PVP together with their respective Affiliates (collectively, the “Venture Investors”), is a professional investment fund, and as such invests in numerous portfolio
companies, some of which may be deemed competitive with the Company’s business (as currently conducted or as currently propose to be conducted). The Company hereby agrees that, to the extent permitted under applicable law, no Venture Investor
shall be liable to the Company for any claim arising out of, or based upon, (i) the investment by a Venture Investor in any entity competitive with the Company, or (ii) actions taken by any partner, officer or other representative of a
Venture Investor to assist any such competitive company, whether or not such action was taken as a member of the board of directors of such competitive company or otherwise, and whether or not such action has a detrimental effect on the Company;
provided, however, that the foregoing shall not relieve (x) any Venture Investor from liability associated with the unauthorized disclosure of the Company’s confidential information obtained pursuant to this Agreement, or (y) any
director or officer of the Company from any liability associated with his or her fiduciary duties to the Company. 
 5.8
Termination of Covenants. The covenants set forth in this Section 5 (other than Section 5.5) shall terminate and be of no further force or effect (i) immediately before the consummation of the Qualified IPO, (ii) when the
Company first becomes subject to the periodic reporting requirements of Section 12(g) or 15(d) of the Exchange Act, or (iii) upon a Deemed Liquidation Event, whichever event occurs first. 

6. MISCELLANEOUS. 

6.1 Successors and Assigns. The rights under this Agreement may be assigned (but only with all related obligations) by a
Holder to a transferee of Registrable Securities that (i) is an Affiliate of a Holder; (ii) is a Holder’s Immediate Family Member or trust for the benefit of an individual Holder or one or more of such Holder’s Immediate Family
Members; or (iii) after such transfer, holds at least fifty percent (50%) of the shares of Registrable Securities originally held by the assignor prior to the transfer of shares (subject to appropriate adjustment for stock splits, stock
dividends, combinations, and other recapitalizations); provided, however, that (x) the Company is, within a reasonable time after such transfer, furnished with written notice of the name and address of such transferee and the
Registrable Securities with respect to which such rights are being transferred; and (y) such transferee agrees in a written instrument delivered to the Company to be bound by and subject to the terms and conditions of this Agreement, including
the provisions of Subsection 2.11. For the purposes of determining the number of shares of Registrable Securities held by a transferee, the holdings of a transferee (1) that is an Affiliate or stockholder of a Holder; (2) who is a
Holder’s Immediate Family Member; or (3) that is a trust for the benefit of an individual Holder or such Holder’s Immediate Family Member shall be aggregated together and with those of the transferring Holder; provided
further that all transferees who would not qualify individually for assignment of rights shall have a single attorney-in-fact for the purpose of exercising any
rights, receiving notices, or taking any action under this Agreement. The terms and conditions of this Agreement inure to the benefit of and are binding upon the respective successors and permitted assignees of the parties. Nothing in this
Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and permitted assignees any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as
expressly provided herein. 
 6.2 Governing Law. This Agreement shall be governed by the internal law of the State of
Delaware, without regard to conflict of laws principles. 

  
 18 

 6.3 Counterparts.. This Agreement may be executed in two (2) or more
counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. Counterparts may be delivered via facsimile, electronic mail (including pdf or any electronic signature complying with
the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions Act or other applicable law) or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be valid and effective for all
purposes. 
 6.4 Titles and Subtitles. The titles and subtitles used in this Agreement are for convenience only and are not to
be considered in construing or interpreting this Agreement. 
 6.5 Notices. All notices and other communications given or made
pursuant to this Agreement shall be in writing and shall be deemed effectively given upon the earlier of actual receipt or (i) personal delivery to the party to be notified; (ii) when sent, if sent by electronic mail or facsimile during
the recipient’s normal business hours, and if not sent during normal business hours, then on the recipient’s next business day; (iii) five (5) days after having been sent by registered or certified mail, return receipt requested,
postage prepaid; or (iv) one (1) business day after the business day of deposit with a nationally recognized overnight courier, freight prepaid, specifying next-day delivery, with written verification of
receipt. All communications shall be sent to the respective parties at their addresses as set forth on SCHEDULE A hereto, or to the principal office of the Company and to the attention
of the Chief Executive Officer, in the case of the Company, at the address set forth on the Company signature page hereto; and a copy (which shall not constitute notice) shall also be sent to Cooley LLP, 3175 Hanover Street, Palo Alto, CA 94304,
Attention: Josh Seidenfeld. 
 6.6 Amendments and Waivers. Except as set forth herein, any term of this Agreement may be
amended and the observance of any term of this Agreement may be waived (either generally or in a particular instance, and either retroactively or prospectively) only with the written consent of the Company and the holders of a majority of the
Registrable Securities then outstanding; provided that the Company may in its sole discretion waive compliance with Subsection 2.12(c) (and the Company’s failure to object promptly in writing after notification of a
proposed assignment allegedly in violation of Subsection 2.12(c) shall be deemed to be a waiver); and provided further that any provision hereof may be waived by any waiving party on such party’s own behalf, without
the consent of any other party. Notwithstanding the foregoing, (i) this Agreement may not be amended or terminated and the observance of any term hereof may not be waived with respect to any Investor without the written consent of such
Investor, unless such amendment, termination, or waiver applies to all Investors in the same fashion, (ii) Sections 1.17, 3.1, 3.2, 4, and this clause (ii) may not be amended or terminated and the observance of
any term hereof may not be waived without the prior written consent of the Major Investors holding a majority of the Registrable Securities then outstanding held by all Major Investors (it being agreed that a waiver of the provisions of
Section 4 with respect to a particular transaction shall be deemed to apply to all Major Investors in the same fashion if such waiver does so by its terms, notwithstanding the fact that certain Major Investors may
nonetheless, by agreement with the Company, purchase securities in such transaction), (iii) SCHEDULE A hereto may be amended by the Company from time to time in accordance with the Purchase Agreement to add information
regarding Additional Purchasers (as defined in the Purchase Agreement) without the consent of the other parties hereto, (iv) any provision hereof may be waived by the waiving party on such party’s own behalf, (v) the last sentence of
Subsection 1.17 and this clause (v) may not be amended or waived without the written consent of Y Combinator Continuity Fund I, L.P. and YCVC Fund I, L.P., (vi) Sections 1.4 and 5.7, as applied to EVFI, EF III, Seraph, EPQ
LFLU and EPQ LCOVD, as applicable, may not be amended or terminated and the observance of any term hereof may not be waived without the prior written consent of EVFI, EF III, Seraph, EPQ LFLU and EPQ LCOVD, as applicable. The Company shall give
prompt notice of any amendment or termination hereof or waiver hereunder to any party hereto that did not consent in writing to such amendment, termination, or waiver. Any amendment, termination, or waiver effected in accordance with this
Subsection 6.6 shall be binding on all parties hereto, 

  
 19 

 
regardless of whether any such party has consented thereto. No waivers of or exceptions to any term, condition, or provision of this Agreement, in any one or more instances, shall be deemed to be
or construed as a further or continuing waiver of any such term, condition, or provision. 
 6.7 Severability. In case any one
or more of the provisions contained in this Agreement is for any reason held to be invalid, illegal or unenforceable in any respect, such invalidity, illegality, or unenforceability shall not affect any other provision of this Agreement, and such
invalid, illegal, or unenforceable provision shall be reformed and construed so that it will be valid, legal, and enforceable to the maximum extent permitted by law. 

6.8 Aggregation of Stock. All shares of Registrable Securities held or acquired by Affiliates shall be aggregated together for
the purpose of determining the availability of any rights under this Agreement and such Affiliated persons may apportion such rights as among themselves in any manner they deem appropriate. 

6.9 Additional Investors. Notwithstanding anything to the contrary contained herein, if the Company issues additional shares of
the Company’s Preferred Stock after the date hereof, any purchaser of such shares of Preferred Stock may become a party to this Agreement by executing and delivering an additional counterpart signature page to this Agreement, and thereafter
shall be deemed an “Investor” for all purposes hereunder. No action or consent by the Investors shall be required for such joinder to this Agreement by such additional Investor, so long as such additional Investor has agreed in writing to
be bound by all of the obligations as an “Investor” hereunder. 
 6.10 Specific Performance. In addition to any and
all other remedies that may be available at law in the event of any breach of this Agreement, each Investor shall be entitled to specific performance of the agreements and obligations of the Company hereunder and to such other injunction or other
equitable relief as may be granted by a court of competent jurisdiction. 
 6.11 Further Assurances. At any time or from time
to time after the date hereof, the parties agree to cooperate with each other, and at the request of any other party, to execute and deliver any further instruments or documents and to take all such further action as the other party may reasonably
request in order to evidence or effectuate the consummation of the transactions contemplated hereby and to otherwise carry out the intent of the parties hereunder. 

6.12 Entire Agreement. Upon the effectiveness of this Agreement, the Prior Agreement shall be deemed amended and restated and
superseded and replaced in its entirety by this Agreement and shall be of no further force or effect. This Agreement (including any Schedules hereto) constitutes the full and entire understanding and agreement among the parties with respect to the
subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties is expressly canceled. 

6.13 Dispute Resolution. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the state
courts of California and to the jurisdiction of the United States District Court for the District of Northern California for the purpose of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree not to
commence any suit, action or other proceeding arising out of or based upon this Agreement except in the state courts of California or the United States District Court for the District of Northern District, and (c) hereby waive, and agree not to
assert, by way of motion, as a defense, or otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from attachment or
execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such court. 

  
 20 

 6.14 Attorneys’ Fees. If any action at law or in equity
(including, arbitration) is necessary to enforce or interpret the terms of any of this Agreement, the prevailing party shall be entitled to reasonable attorneys’ fees, costs and necessary disbursements in addition to any other relief to which
such party may be entitled. 
 6.15 Delays or Omissions. No delay or omission to exercise any right, power, or remedy accruing
to any party under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power, or remedy of such nonbreaching or nondefaulting party, nor shall it be construed to be a waiver of or
acquiescence to any such breach or default, or to any similar breach or default thereafter occurring, nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. All
remedies, whether under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative. 
 6.16
Acknowledgment. The Company acknowledges that the Investors are in the business of venture capital investing and therefore review the business plans and related proprietary information of many enterprises, including enterprises which may have
products or services which compete directly or indirectly with those of the Company. Nothing in this Agreement shall preclude or in any way restrict the Investors from investing or participating in any particular enterprise whether or not such
enterprise has products or services which compete with those of the Company. 
 [SIGNATURE PAGES
FOLLOW] 

  
 21 

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	COMPANY:
	
	LUCIRA HEALTH, INC.
		
	By:	 	 /s/ Erik T. Engelson 

	Name:	 	 Erik T. Engelson

	Title:	 	 Chief Executive Officer

		
	Address:	 	 1412 62nd Street

		 	 Emeryville, CA 94608

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	AISOMI LLC
		
	By:	 	 /s/ Tamara L. Minick-Sokalo

	Name:	 	 Tamara L. Minick-Sokalo

	Title:	 	 Director

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	BERENSTEIN FAMILY GST EXEMPT 2009 TRUST
		
	By:	 	 /s/ Frank A. Sisti

	Name:	 	 Frank A. Sisti

	Title:	 	 Trustee

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	BLUE DEVIL TRUST
		
	By:	 	 /s/ David Lamond

	Name:	 	 David Lamond 

	Title:	 	 Trustee

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	CAROL OLSON LIVING TRUST DATED 6/9/2014
		
	By:	 	 /s/ Carol Olson

	Name:	 	 Carol Olson

	Title:	 	 Trustee

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	CHRISTINE HANNI
	
	/s/ Christine Hanni
	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	DAN GEORGE
	
	/s/ Dan George
	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	DANIEL HEILBRUNN
	
	/s/ Daniel Heilbrunn
	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	DAVID ROGERS
	
	/s/ David Rogers
	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	EPQ LLC, LCOVD PS
		
	By:	 	/s/ Chad Boeding
	Name:	 	Chad Boeding
	Title:	 	CEO

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	GAURAV GANDHI
	
	/s/ Gaurav Gandhi
	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	GC&H INVESTMENTS, LLC
		
	By:	 	/s/ Jim Kindler 
	Name:	 	Jim Kindler
	Title:	 	Manager

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	H. BARTON CO-INVEST FUND IV, LLC
	 By: H. Barton Asset Management, LLC

Its: Managing Member

		
	By:	 	/s/ Harris Barton 
	Name:	 	Harris Barton
	Title:	 	Managing Member

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	HARRY AND ROSE PAPP REVOCABLE TRUST U/A DTD 2/9/1990
		
	By:	 	/s/ Harry Papp 
	Name:	 	Harry Papp
	Title:	 	Trustee

  

			
	By:	 	/s/ Rose Papp 
	Name:	 	Rose Papp
	Title:	 	Trustee

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	HARRY SMOUSE
	
	/s/ Harry Smouse
	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	JASON ODERIO
	
	/s/ Jason Oderio
	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	JASON VAN TASSEL
	
	/s/ Jason Van Tassel
	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	JAYA KARNANI
	
	/s/ Jaya Karnani
	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	JULIE A. WRIGLEY 1999 REVOCABLE TRUST
		
	By:	 	 /s/ Julie A. Wrigley

	Name:	 	 Julie A. Wrigley

	Title:	 	 Trustee

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	KELLY LEWIS BREZOCZKY AND FLOYD C. LEWIS
	
	 /s/ Kelly Lewis Brezoczky

	(Signature)
	
	 /s/ Floyd C. Lewis

	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	KENNETH MAHAFFEY
	
	 /s/ Kenneth Mahaffey

	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	KEVIN KNIGHT
	
	 /s/ Kevin Knight

	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	KNIGHT FAMILY TRUST (EST 3/10/2003)
		
	By:	 	 /s/ Peggy L. Day

	Name:	 	 Peggy L. Day

	Title:	 	 Trustee

		
	By:	 	 /s/ Delos L. Knight III

	Name:	 	 Delos L. Knight III

	Title:	 	 Trustee

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	LAKE MIDAS, LLC
		
	By:	 	 /s/ Jason J. Oderio

	Name:	 	 Jason J. Oderio

	Title:	 	 Manager

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	LATERAL CAPITAL V, L.P.
	By: Lateral Capital V General Partner, LLC
	Its: General Partner
		
	By:	 	 /s/ John Lilly

	Name:	 	 John Lilly

	Title:	 	 Managing Member

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	PACIFIC PREMIER TRUST CUSTODIAN FBO JOSEPH S. ANDRESEN
		
	By:	 	 /s/ Joseph S. Andresen

	Name:	 	 Joseph S. Andresen

	Title:	 	 Investor

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	PACIFIC PREMIER TRUST CUSTODIAN FBO ERIK ENGELSON IRA
		
	By:	 	 /s/ Erik T. Engelson

	Name:	 	 Erik T. Engelson

	Title:	 	 Authorized Signatory

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	PETER AND KRISTA DALTON
	
	/s/ Peter Dalton
	(Signature)
	
	 /s/ Krista Dalton

	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	PETER S. BROWN
	
	/s/ Peter S. Brown
	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	PHOENIX VENTURE PARTNERS III LP
		
	By:	 	 /s/ Zachariah Jonasson

	Name:	 	 Zachariah Jonasson

	Title:	 	 Principal

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	RUSSELL A. BIEHL AND ROBIN R. BIEHL, TRUSTEES OF THE RUSSELL A.
BIEHL AND ROBIN R. BIEHL LIVING TRUST DTD. 6/11/2018
		
	By:	 	 /s/ Russell A. Biehl

	Name:	 	 Russell A. Biehl

	Title:	 	 Trustee

		
	By:	 	 /s/ Robin R. Biehl

	Name:	 	 Robin R. Biehl

	Title:	 	 Trustee

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	SERAPH INVESTMENTS II, LLC
		
	By:	 	 /s/ Tuff Yen

	Name:	 	 Tuff Yen

	Title:	 	 Manager

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	STEPHANIE L. GNIBUS
	
	 /s/ Stephanie L. Gnibus

	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	THE SAADAT FAMILY LIVING TRUST
		
	By:	 	/s/ Mojgan Saadat
	Name:	 	 Mojgan Saadat

	Title:	 	 Co-Trustee

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	THEODORE L. POST
	
	 /s/ Theodore L. Post

	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	THERESA BRANDNER
	
	 /s/ Theresa Brandner

	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	WILLIAM JASON FOX
	
	 /s/ William Jason Fox

	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	YCVC FUND I, L.P.
	By: YCVC Fund GP, LLC,
	its General Partner
		
	By:	 	 /s/ Kristy Nathoo 

	Name:	 	Kristy Nathoo
	Title:	 	Chief Financial Officer
	
	335 Pioneer Way
	Mountain View, CA 94041
	
	fiancings@ycombinator.com

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	ECLIPSE VENTURES FUND I, L.P.
	By: Eclipse Ventures GP I, LLC
	Its General Partner
		
	By:	 	 /s/ Justin Butler 

	Name:	 	Justin Butler
	Title:	 	Partner

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	ECLIPSE FUND III, L.P.
	By: Eclipse GP III, LLC
	Its General Partner
		
	By:	 	 /s/ Justin Butler 

	Name:	 	 Justin Butler

	Title:	 	 Partner

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	WILMOT VENTURES, L.P. – SERIES A
		
	By:	 	 /s/ Daniel Lurie

	Name:	 	 Daniel Lurie

	Title:	 	 General Partner

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

	
	INVESTOR:
	
	DANIEL L. LURIE
	
	 /s/ Daniel L. Lurie

	(Signature)

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 IN WITNESS WHEREOF, the
parties have executed this AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT as of the date first written above. 

 

			
	INVESTOR:
	
	DANAHER INNOVATION CENTER LLC
		
	By:	 	 /s/ Michael Egholm

	Name:	 	 Michael Egholm

	Title:	 	 Vice President

  

SIGNATURE PAGE TO 

AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT

 SCHEDULE A 

INVESTORS

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]